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Summary 
Within the Australian population, arthritis and other musculoskeletal conditions are highly 
prevalent, associated with significant disability, and generate large costs for the health and 
welfare systems. It is important to monitor these conditions to describe existing health 
patterns, populations at risk of illness, current health service use, and future demands on the 
health and welfare systems.  
This report assesses the potential for existing data sources to improve our understanding of 
arthritis and other musculoskeletal conditions. Although many of the data sources identified 
were not primarily designed for monitoring these conditions, they do contain relevant data.  
A 4-step process is used to assess the utility of different of data sources, including an initial 
stocktake of data collections, a review of in-scope data collections, an assessment of 
individual data collections and lastly an overall assessment of data collections collectively. 
This methodological approach can be used to assess other data sources for different 
conditions. 
This report acknowledges: 
• Data are available for: 
– risk factors, including some relevant information from longitudinal surveys  
– prevalence, with the exception of rarer conditions. 
• Data are available but require further development for: 
– prevention, treatment and management, particularly to fill substantial gaps in 
relation to prevention activity and the use and appropriateness of care provided in 
primary health-care settings 
– death and disability, noting additional information is expected in late 2015 from new 
Australian estimates of burden of disease. 
• Data require development for: 
– quality of life 
– health expenditure. 
• Future opportunities for improving data include: 
– data linkage to enhance the information that can be gained using existing data  
– enhancing the current lack of primary health-care data 
– improving consistency and comparability of data from different sources by 
encouraging development and implementation of information standards 
– regular/ongoing collection of data to enable the assessment of change over time. 
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1 Introduction 
The purpose of this report is to assess the potential for existing data sources to improve our 
understanding of arthritis and other musculoskeletal conditions. It is not intended to make 
value judgments about the selected data sources per se but to assess their utility to provide 
relevant information for these conditions. 
Many data sources currently exist that potentially could be used to improve our 
understanding of arthritis and other musculoskeletal conditions. As many of these data 
sources were not primarily designed for arthritis monitoring, this report examines their 
utility in providing relevant information on key areas of interest, such as risk factors, 
prevalence, prevention, management and treatment, impact (quality of life, death and 
disability) and cost.  
1.1 Structure of the report 
This chapter outlines the purpose and scope of the report, the key questions relevant for 
monitoring arthritis and other musculoskeletal conditions, and our assessment approach.  
Chapter 2 provides an overview of the types of data sources available for disease monitoring 
and identifies those data relevant for monitoring arthritis and other musculoskeletal 
conditions (including a reference table).  
Chapter 3 outlines, in detail, the extent to which existing data sources can answer the key 
questions for monitoring arthritis and other musculoskeletal conditions.  
Chapter 4 discusses and summarises the overall findings and suggests future opportunities 
for data development. 
1.2 Why monitor arthritis and other 
musculoskeletal conditions? 
Disease monitoring, in general, is important for keeping a close watch over the public’s 
health and health services. Data collected through disease monitoring can be used to 
examine existing and emerging health patterns, population groups at risk of ill health, 
current health service use and future demand on the health system.  
Monitoring assists with allocating resources, planning preventive and treatment services and 
with targeting priority population groups. Monitoring also assists with tracking the impact 
of risk factors, improvements in diagnosis, health promotion activities, treatment and 
prevention strategies, and informing development of new policies and programs and 
evaluating their progress. 
Monitoring arthritis and other musculoskeletal conditions is important because of their: 
• high prevalence within the population 
• significant association with disability across the life course 
• impact on the health and quality of life of sufferers 
• cost burden to individuals and the health system. 
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Prevalence 
Current estimates show 6.1 million Australians have arthritis or other long-term 
musculoskeletal conditions (ABS 2012) and this number is expected to rise as the population 
ages. While these conditions predominantly affect older populations, they are also 
experienced by those in younger age groups (ABS 2012). 
Arthritis affects an estimated 3.3 million people, which includes osteoarthritis (1.8 million), 
rheumatoid arthritis (0.4 million) and other forms of arthritis (1.1 million). Back pain/disc 
disorders affects an estimated 2.8 million people and osteoporosis affects 0.7 million people 
(ABS 2012).  
Quality of life, physical functioning and disability  
Arthritis and other musculoskeletal conditions have a substantial impact on the health and 
quality of life of sufferers. While not often a direct cause of death, these conditions make a 
large contribution to pain, mobility restriction and functional impairment, as well as 
affecting mental health and overall quality of life (AIHW 2008a). An estimated 1.4 million 
Australians report arthritis and other musculoskeletal conditions as their main long-term 
health condition. In terms of the effect on physical functioning, just over half (57%) of these 
Australians report they have mild or moderate core activity limitation and more than a 
quarter (28%) report severe or profound core activity limitation (ABS 2013). 
In addition, according to the 2010 Global Burden of Disease Study, ‘musculoskeletal 
disorders’ were the highest ranking cause of health lost due to disability in Australasia 
(Australia and New Zealand), contributing just over a quarter (26.4%) of the non-fatal 
burden (IHME 2013). See Box 1.1 for further details of musculoskeletal disorders. 
Cost burden 
Arthritis and other musculoskeletal conditions require ongoing treatment and management 
which, in turn, places a large cost burden on the health-care system, individuals and families. 
During the 2008– 09 financial year, direct health expenditure for arthritis and other 
musculoskeletal conditions was $5.7 billion, the fourth-largest contributor to direct health 
care expenditure in Australia. The two conditions of osteoarthritis and back problems 
accounted for half of this expenditure. Admitted patient services were the biggest 
contributor to overall expenditure (AIHW Disease Expenditure Database).  
In addition to these estimates of direct health expenditure, various modelled estimates of the 
broader concept of ‘health costs’ have been developed. These models include direct  
non-health-care costs, such as home help and meals on wheels, and indirect costs from 
production loss. As a consequence these models provide higher estimates of the costs of 
these conditions (Arthritis and Osteoporosis Victoria 2013; Watts et al. 2013).  
  
  Data sources for monitoring arthritis and other musculoskeletal conditions  3 
Box 1.1: What are musculoskeletal disorders? 
Musculoskeletal disorders include the following: 
Osteoarthritis: A degenerative joint condition mostly affecting the hands, spine and joints 
such as the hips, knees and ankles. Its main feature is the breakdown of the cartilage that 
overlies the ends of the bones in the joints.  
Rheumatoid arthritis: A chronic disease marked by inflammation of the joints, most often 
affecting the hand joints in a symmetrical fashion (that is, both sides of the body are affected 
at the same time). The immune system attacks tissues lining the joints, causing pain, 
swelling and stiffness. Over time there is progressive and irreversible joint damage, 
resulting in deformities and severe disability. The exact cause of rheumatoid arthritis is 
poorly understood but there is a strong genetic component. 
Juvenile arthritis: A common term used to describe arthritis occurring in children under the 
age of 16. The condition typically has an unpredictable pattern of activity, with periods of 
being well followed by a resurgence of signs and severe symptoms such as joint swelling, 
tenderness, heat, stiffness and pain (known as ‘flare-ups’). The cause of juvenile arthritis is 
unknown. 
Back pain: Most cases of back pain do not have an identifiable cause, which is frustrating 
for both patients and care providers. While episodes of back pain may be short-lived, 
recurrence is common and in some cases the pain can become long-lasting. The occurrence 
of back problems has traditionally been associated with age, physical fitness, smoking, 
being overweight and occupation.  
Osteoporosis: Thinning and weakening of bones often occurs with age, increasing the risk 
of fracture. While osteoporosis occurs in both sexes, it is more common in women. Risk 
factors for osteoporosis include increasing age, female sex, family history of the condition, 
low vitamin D levels, low intake of calcium, low body weight, smoking, excessive alcohol 
consumption, physical inactivity, long-term corticosteroid use and reduced oestrogen 
levels.  
Other musculoskeletal conditions include gout, spondylopathies, osteomyelitis, systemic 
lupus erythematosus, ankylosing spondylitis, tendinitis, carpal tunnel syndrome and 
fibromyalgia.  
Source: AIHW forthcoming. 
1.3 Information needed for monitoring 
To evaluate the data available for monitoring a specific disease, it is important to know what 
type of information is required. Various existing frameworks provide a useful guide for the 
selection of indicators that assist in understanding and evaluating the health of Australians 
and performance of the health system.  
One such model is the National Health Performance Framework created under the auspices 
of the Australian Health Ministers’ Advisory Council (NHISSC 2009). A modified version of 
this model is depicted in Table 1.1 and describes 5 categories of public health information 
that are required to monitor disease in a population, namely population health status; 
determinants of health; public health interventions; inputs and infrastructure, and priority 
populations. This model was used to help identify the general information areas for 
monitoring arthritis and other musculoskeletal conditions. 
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Table 1.1: Categories of public health information required for disease monitoring 
Population health 
status 
Determinants of 
health 
Public health 
interventions 
Inputs and 
infrastructure 
Priority populations  
Health conditions and 
injury 
Environmental 
factors 
Hospitalisation Labour force Aboriginal and Torres Strait 
Islander peoples 
Human functioning 
and disability 
Community and 
socioeconomic  
General practitioner 
visits 
Expenditure, funding 
and capital 
infrastructure 
Residents of rural and 
remote locations 
Mortality Health behaviours Treatments Training People with a low 
socioeconomic status 
Quality of life  Biomedical factors 
(including genetics 
and family history) 
Allied health care Research Non-English speakers 
  Public health education  People with disability 
  Disability and other 
non-health support 
services 
 Homeless people 
Source: Modified from AIHW 2012a. 
1.4 The disease continuum for arthritis and other 
musculoskeletal conditions 
While the model outlined in Table 1.1 describes the general types of information needed for 
monitoring a chronic disease, it does not describe the detailed issues specific to arthritis and 
other musculoskeletal conditions that need to be monitored.  
A model of the continuum of care for arthritis and other musculoskeletal conditions, based 
on work by the former Department of Health and Ageing, National Arthritis and Other 
Musculoskeletal Conditions Advisory Group, and National Public Health Partnership, 
describes the interventions required by individuals at each stage of the disease, and the 
health-care sectors responsible for providing treatment and care (Figure 1.1).  
As arthritis and other musculoskeletal conditions are generally chronic diseases, information 
required for monitoring the conditions in each category described in Table 1.1 changes over 
the disease continuum. The stages of the disease continuum include the well population,  
at-risk/asymptomatic population, population with a recent disease diagnosis, population 
managing a chronic disease, and population receiving palliative care or who have died from 
the condition.  
The aim of public health interventions is to prevent people moving to subsequent stages of 
the disease continuum by ensuring they receive timely and appropriate treatment suitable to 
their current health status. To evaluate whether this is happening, a comprehensive 
monitoring system includes information about a range of preventive activities, from health 
promotion to treatment (for example population-wide, musculoskeletal conditions in 
general, disease-specific, focused on those with known genetic pre-disposition); from a range 
of health sectors, and from other sectors such as planning authorities (for example ‘Healthy 
City’ planning [WHO 2014]) and professional groups.  
Clinical guidelines for managing specific musculoskeletal conditions (for example, RACGP 
2009a, 2009b, 2009c, 2010) and models of care for arthritis (Arthritis Australia 2014) are also 
relevant in considering the types of information needed to monitor progress.
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 Stage of disease continuum 
 Well population 
 
At-risk or asymptomatic 
 
Diagnosis of disease 
 
Management of chronic 
disease  
Mortality 
Level of 
prevention 
Primary prevention 
 
Secondary prevention/ early 
detection  
Disease management, tertiary prevention and rehabilitation 
 
Disease management 
Nature of 
intervention 
Promotion of healthy 
behaviours and 
environments across the life 
course: 
 Promote weight control
(a)
 
 Promote joint injury or 
trauma prevention
(a)(c)
 
 Prevent smoking
(a)(b)
 
 Promote behaviours to 
improve bone health 
including nutrition, 
exercise and moderate 
alcohol consumption
(c)
 
 Address occupational 
risks
(d)
 
Universal and targeted 
approaches 
 
Education programs 
Screening: 
 Bone mineral density 
screening 
(c)
 
Case finding 
Periodic health examinations: 
 Promote weight control and 
joint injury prevention
(a)
 
 Early intervention; tailored to 
condition e.g. early 
recognition of symptoms and 
prompt referral to allied 
health/self-management
(a)(d)  
or specialist services as 
appropriate 
 Intervene to prevent first 
fracture 
Control risk factors  
Treatment and acute care, 
including pain management 
Complications management 
including comorbidity 
Preserve function and 
independence 
Promote healthy lifestyle 
behaviours: 
 Initiate disease modifying 
therapy early
(b)
 
 Support attendance at an 
educational program
(b)(c)
 
 Consider occupational 
intervention
(b)
 
 Identify people with minimal 
trauma fracture
(c)
 
 Intervene to prevent further 
fractures
(c)
  
Continuing care 
Maintenance 
Optimise therapy and 
symptom relief 
 Provide timely access to 
joint replacement surgery 
and multidisciplinary 
care
(a)(b)
 
Disability support and 
management 
Improve functioning (social 
and physical): 
Self-management 
Psychosocial support: 
 Intervene to prevent 
further fractures
(c)
 
Improve health-related 
quality of life  
Manage pain and 
discomfort 
Improve health-related 
quality of life 
Responsible 
sectors 
Public health initiatives 
Primary health care 
Other sectors  
Primary health care 
Public health initiatives 
 
Specialist services 
Hospital care 
Primary health care  
Primary health care 
Community care 
Specialist services  
Hospital care 
Primary health care 
Community care 
 Prevent movement to 
at-risk group  
Prevent/delay progression 
to complications  
Prevent progression to 
established disease  
Delay progression of 
complications  
 
(a) Particularly relevant to osteoarthritis. 
(b) Particularly relevant to rheumatoid arthritis. 
(c) Particularly relevant to osteoporosis. 
(d) Particularly relevant to back problems. 
Sources: Modified from DoHA & NAMSCAG 2004; National Public Health Partnership 2001. 
Figure 1.1: Public health activities across the disease continuum for arthritis and other musculoskeletal conditions  
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1.5 Priority information areas and key questions 
For this report, the two models presented in Table 1.1 and Figure 1.1 were used to formulate 
a simplified set of 6 priority information areas for monitoring arthritis and other 
musculoskeletal conditions. For accurate monitoring, information is required to describe 
various dimensions of the conditions, including their risk factors, prevalence, how effectively 
the health system is responding through prevention and treatment, the impact (measured in 
quality of life, death and disability) and health expenditure. Information is needed to 
describe the situation at a particular point in time and to track changes over time.These 
priority information areas translate into the following 6 key questions which are used to 
guide the remainder of this report (Box 1.2). 
Box 1.2:  Key questions for monitoring arthritis and other musculoskeletal conditions 
1. Risk factors: What proportion of the population experience the modifiable risk factors 
associated with arthritis and other musculoskeletal conditions?  
2. Prevalence: What is the prevalence of (that is, how common are) arthritis and other 
musculoskeletal conditions in the population?  
3. Prevention, management and treatment: What prevention, management and treatment 
services do the population with arthritis and other musculoskeletal conditions receive? 
4. Quality of life: How do arthritis and other musculoskeletal conditions affect an 
individual’s quality of life? 
5. Death and disability: How much death and disability is associated with arthritis and 
other musculoskeletal conditions?  
6. Health expenditure: What is known about expenditure on arthritis and other 
musculoskeletal conditions?  
Wherever possible, these questions are examined in relation to arthritis and other 
musculoskeletal conditions overall, and then for each of the specific conditions (juvenile 
idiopathic arthritis, rheumatoid arthritis, osteoarthritis, back problems, osteoporosis and 
‘other’ musculoskeletal conditions). The approach taken in this report is to establish the 
extent to which information is available to answer the key questions in Box 1.2 and refer to 
examples of more complex follow-up questions in the discussion (Chapter 4). 
1.6 Assessment approach 
This report describes and assesses data sources for monitoring arthritis and other 
musculoskeletal conditions in Australia, to identify gaps and deficiencies in the current 
information base for regular monitoring. Given the population health monitoring focus of 
this report, data sources that are nationally representative are considered advantageous. The 
data sources selected for inclusion in this report are not necessarily superior to other 
collections in general. The authors acknowledge that each data set was established for a 
particular purpose, not necessarily with musculoskeletal monitoring as its primary purpose.  
Depending on the user’s information needs, it is possible that many regional or other data 
collections reviewed will provide some answers to specific questions about arthritis and 
other musculoskeletal conditions. The AIHW used the 4-step process, outlined in Figure 1.2, 
to assess the suitability of current data collections in Australia to answer the key questions 
for monitoring arthritis and other musculoskeletal conditions.  
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Figure 1.2: Assessment framework for determining the suitability of current data collections for 
monitoring arthritis and other musculoskeletal conditions 
Step 1: Stocktake of national and local data sources to identify ‘in-scope’ collections 
(Chapter 2) 
Data sources included were not intended to be exhaustive but focused on information: 
•  about arthritis or other musculoskeletal conditions in relation to one or more of the six 
  priority information areas; and 
•  representative of the Australian population; or  
•  smaller regional/localised studies (at least 1,000 subjects) with a musculoskeletal focus. 
Step 2: Detailed review of all in-scope collections (Chapter 2 and Appendix 1)  
Information included: 
•  data source characteristics: title, type (administrative, survey etc.), description,  
  purpose, collection management, where to go for further information 
•  methodology: scope, geographical coverage, frequency/timing 
•  information on which priority information areas are included in the data source (for  
  example, risk factors, prevalence, prevention, management, treatment and impact). 
Step 3: Relevance of data sources to priority information areas (Chapter 3) 
The following five categories were assigned to the selected data sources to determine 
their usefulness for informing the relevant priority area:  
•  Representative national data that provides comprehensive information 
•  Representative state/territory/regional data that provides  
  comprehensive information, or 
  Representative national data that provides  partial information 
•  Non-representative national data, or representative 
  state/territory/regional data that provides partial information 
•  Non-representative state/territory/regional data. 
•  Other – there are limitations with the use or interpretability of the  
   data; however, it may have some benefit to monitoring. 
Note: Also considered in the category rating were issues such as currency of the data 
and whether collections are ongoing (Category ratings modified from AIHW 2011a). 
Step 4: Comparative assessment (Chapter 4) 
•   A comparative assessment undertaken, based on the number of relevant data 
    sources,  individual  category ratings, and an overall assessment of relative depth  
   and breadth of data  available in each  priority information area (spanning both  
   nationally representative  information and complementary information).  
•   This is an ‘on balance’ assessment considering the relative strength of information  
    available across all  of the priority information areas. 
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2 Data source descriptions 
A number of data sources provide public health information in Australia. Based on the 
mechanism of data collection, the data sources can be categorised as administrative, survey, 
registry, derived and longitudinal. The information in these data sources is obtained from 
individuals, government agencies and private and community organisations and health 
professionals. A disease monitoring system can include one or more of these data sources to 
inform the population health issue in question. 
Information from these sources may be collected continuously over many years, allowing  
in-depth analysis of health service use for a given month, year or over time. Surveys may be 
conducted periodically or ‘once-off’ and can provide a snapshot at one point in time, 
including possible comparison with similar cross-sectional data collected at an earlier or later 
time.  
Data may be collected and reported at a national, state/territory or local level. National data 
sources are beneficial as they provide information at a population level and are often 
representative; that is, participants closely match the characteristics of the population, which 
enables the results to be generalised to the whole population. 
Public health information obtained at the state and territory level can provide data that 
complements, or can be used as a substitute for, national data, depending on the collection 
methods and representativeness.  
Regional and local data can also be very useful, particularly in understanding the needs of 
local communities and the extent to which available services meet these needs. There is 
growing demand for data at the local level (for example, Medical Locals health needs 
assessment and planning processes [DoHA 2012]). To meet these local or regional 
requirements, data are essential to develop an understanding of the population and identify 
opportunities to improve health; assess existing health-care services to determine what is 
working, what would be improved and where resources could be used differently; 
implement initiatives; and monitor performance (DoHA 2012).  
Limitations are often associated with using state/territory, regional or local data as they may 
not be representative or complete. For example, comprehensive, coordinated or standardised 
primary health care information is not presently collected at the state/territory, regional or 
local level in Australia.  
While recognising the need for information at all of the above levels, the ‘representativeness’ 
assessment of data sources undertaken in this review (Step 3) focuses on the national 
representativeness of each data source.  
2.1 Types of data sources 
Administrative data sources 
Administrative data are collected as a by-product of the delivery of health services. For 
example, data are recorded during a visit to a general practitioner or hospital admission, or 
through other processes, such as registrations of births, deaths or marriages.  
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Administrative data sources can capture information on the majority, if not all, of people 
receiving a particular service or program. These datasets generally: 
• have good coverage of person and service characteristics 
• are collected on an ongoing basis and reported frequently 
• have sufficient coverage for use at the national, state and territory or regional level. 
In addition, where scope, coverage and data quality are consistent over time, administrative 
datasets provide a valuable source of time series information. There are, however, limitations 
associated with administrative data sources, because they are: 
• by their nature, the by-product information from existing health activities (such as 
admission to a hospital), therefore limited to specific scope, coverage and data elements 
available as a cost-effective by-product of that activity 
• collected for a particular purpose and then possibly used for a secondary purpose 
(including aggregate reporting); therefore these sources cannot usually tell us about the 
non-users of a given program or service type, may not include the depth of information 
to inform all questions of interest, and may not produce reliable estimates for all regions 
(depending on coverage) 
• limited by the quality and completeness of information provided for each data element. 
Survey-based data sources 
Survey-based data sources collect health-related information, often by way of a population 
sample. Survey data include details relating to the experience of the individual surveyed 
across a range of services and health conditions and can provide a greater depth of 
information than administrative data. Where question design, sampling and data quality are 
consistent over time, population health surveys provide a valuable source of time series 
comparisons.  
There are also inherent limitations to this methodology. Respondents may misreport 
information, either intentionally or unintentionally, which reduces the accuracy of the 
results. For example, respondents may be unable to recall health events, food intakes, 
medications or medical advice, particularly over a long time. Additionally, the sampling 
method for most population surveys is not designed to produce reliable estimates at regional 
levels nor for small, but important, sub-populations. 
Registry data sources 
Registries aim to systematically collect detailed information on persons with a certain disease 
or receiving a particular treatment. The data can be used to determine the incidence of an 
event or a disease, and the nature of an intervention or procedure. However, the data are 
specific to these events and usually do not include information from the general population.  
It is difficult to generalise the results from registries to the population as a whole. Further, 
findings derived from registry data may be limited in instances where full coverage of the 
relevant disease or treatment population is not obtained. For example, unless registries are 
supported by business processes, audits, mandatory data entry or by-product information 
from other technology, their complete coverage cannot be guaranteed. 
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Derived data sources 
Derived data sources use information from other data sources to produce new measures. 
Some examples are to derive summary measures or monetary costs of a disease or condition. 
The accuracy and validity of the data are dependent on the quality of the underlying data, 
the methods used to calculate the derived data and any assumptions made. Derived data can 
be a powerful way of summarising information from a range of sources and can allow 
comparisons across variables or factors (for example, disease types, risk factors and type of 
health service). 
Longitudinal data sources 
Longitudinal studies involve following a cohort of individuals over time with continuous 
monitoring of risk factors and/or health outcomes. The length of the study may vary, with 
some longitudinal studies running for decades. Longitudinal studies are useful as they 
provide important data about changes experienced by individuals over time and allow for 
flexibility in the data collected at each time point. However, such studies are time-consuming 
(which affects participant retention), potentially costly (in order to maintain a committed 
research team) and not always representative of the general population. 
2.2 In-scope data sources for arthritis and other 
musculoskeletal monitoring 
The first step in assessing the suitability of data collections for monitoring musculoskeletal 
conditions is to identify ‘in-scope’ data collections (Step 1 of Figure 1.2). The in-scope data 
sources identified are listed in Table 2.1. The data sources included for assessment are not 
exhaustive but focus on those that: 
• contain some information about arthritis or other musculoskeletal conditions in relation 
to one or more of the 6 areas of interest; and 
• are representative of the Australian population; or  
• are smaller regional/localised studies (with at least 1,000 participants) with a 
musculoskeletal focus. 
A detailed review of each source’s relevance to the priority information areas is provided at 
Appendix 1 (Step 2 of Figure 1.2).  
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Table 2.1: In-scope data sources for arthritis and other musculoskeletal conditions 
Type of data source National State, territory or regional 
Administrative 
 
National Hospital Morbidity Database (NHMD) 
National Mortality Database 
Medicare Benefits Scheme (Medicare) 
Pharmaceutical Benefits Scheme and Repatriation 
Pharmaceutical Benefits Scheme (PBS and RPBS) 
Non-admitted patient care aggregate national 
minimum data set specification (Non-admitted 
patient care aggregate NMDS). 
National Non-Admitted Patient Emergency 
Department Care Database (NNAPEDCD) 
 
Survey 
 
Australian Health Survey (AHS) and National 
Aboriginal and Torres Strait Islander Health Survey 
(NATSIHS) 
Bettering the Evaluation and Care of Health Survey 
of General Practice (BEACH) 
Survey of Disability, Ageing and Carers (SDAC) 
Voice of Arthritis Social Impact Study 
National Drug Strategy Household Survey 
 
Longitudinal Survey Australian Longitudinal Study on Women’s Health 
(ALSWH) 
The Longitudinal Study of Australian Children 
(LSAC) 
The Longitudinal Study of Indigenous Children 
(LSIC)  
The 45 and up study  
Geelong Osteoporosis Study (GOS) 
North West Adelaide Health Study (NWAHS) 
Australian Longitudinal Study of Aging (ALSA) 
The Tasmanian older adult cohort (TasOAC) 
The Concord Health and Ageing in Men Project 
(CHAMP) 
Florey Adelaide Male Aging Study (FAMAS) 
Dubbo Osteoporosis Epidemiology Study (DOES) 
Registry 
 
Australian Orthopaedic Association National Joint 
Replacement Registry  
Australian Rheumatology Association Database 
(ARAD) 
Optimising Patient Outcome in Australian 
Rheumatology (OPAL) 
 
Derived 
 
Burden of Disease Studies 
AIHW Disease Expenditure Database 
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3 To what extent can in-scope data 
sources answer key questions? 
This section explains Step 3 of Figure 1.2. It identifies the in-scope data sources of most 
relevance to each priority information area (outlined in Box 1.2) and assesses their 
representativeness and completeness for this purpose. For each key question, we describe: 
• Why collect information in this area? 
• What information is available? 
• What information is missing?  
While there is considerable background information to help set the scene for each 
information area, this report provides a summary only and directs readers to other 
information resources as required. 
3.1 Key question 1—Modifiable risk factors 
Why collect information about modifiable risk factors? 
Many factors, often referred to as determinants of health, influence our health and wellbeing 
(see Figure 3.1). Factors affecting health in a negative way are commonly referred to as risk 
factors, for example, high blood pressure can increase the likelihood of developing 
cardiovascular illness. Those affecting health in a positive way are known as protective 
factors, for example, good nutrition and exercise can help prevent many chronic conditions 
(AIHW 2012a).  
Risk factors can be separated into those that are modifiable and those that are not.  
Non-modifiable risk factors include age, sex and family history. While these risk factors 
cannot be modified, information about them can help identify people at high risk of 
developing a disease so that prevention strategies and relevant medical services can be 
devised and located to best effect (AIHW 2008a).  
In contrast, health behaviours are risk factors that individuals have more power to change 
and are, therefore, described as modifiable. Biomedical risk factors are bodily states that 
carry relatively direct and specific risks for health. They are often influenced by health 
behaviours and are therefore potentially modifiable through self-management, health 
promotion and other health interventions (AIHW 2012a).  
This report focuses on the potentially modifiable risk factors in the framework (Figure 3.1) 
—health behaviours and biomedical factors. Understanding patterns of health behaviours 
are important for preventing and managing arthritis and other musculoskeletal conditions. 
These behaviours include meeting the recommended guidelines for physical activity, body 
weight, a nutritious diet, alcohol intake, and not smoking (AIHW 2008a). 
Maintaining appropriate vitamin D levels may also have a role in preventing osteoporosis, 
while avoiding or limiting repetitive load-bearing activities and prevention of joint trauma 
can reduce the risk of developing osteoarthritis (Ebeling et al. 2013). Risk factors for lower 
back pain/disc problems also include excessive mechanical loading of spine (for example 
due to incorrect lifting techniques or poor work design), poor psychosocial health/wellbeing 
and advancing age (Better Health Channel 2013; Hoy et al. 2010). 
  Data sources for monitoring arthritis and other musculoskeletal conditions  13 
 
 
Source: AIHW 2012c. 
Figure 3.1: A conceptual framework for determinants of health 
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Further information on risk factors for musculoskeletal conditions and the presence of risk 
factors in those with and without musculoskeletal conditions is available in AIHW and other 
publications (for example AIHW 2013b, AIHW 2013a, AIHW 2011, AIHW 2008a, National 
Health Priority Action Council 2006). 
In addition, the AIHW publication Risk factors contributing to chronic disease (AIHW 2012c) 
provides a comprehensive picture of risk factor behaviours in Australia, many of which are 
relevant to arthritis and other musculoskeletal conditions.  
What information is available? 
The most relevant data sources for monitoring modifiable risk factors are presented in  
Table 3.1. Our assessment is that the available data sources in this area are ‘Very well 
developed’, consisting of several representative, ongoing data collections, spanning both 
point-in-time collections and longitudinal studies. 
The two main data sources, the Australian Health Survey (AHS) and the Australian 
Longitudinal Study on Women’s Health (ALSWH), collect broad lifestyle risk factor data 
particularly relevant for monitoring arthritis and other musculoskeletal conditions.  
The AHS for 2011-13 is particularly useful because, in addition to self-reported data, it 
collects measured risk factor data, which includes vitamin D levels. Measured data are often 
more reliable than self-reports from participants (AIHW 2012a).  
These data sources are complemented by a number of other national and state-based 
surveys, some of which are ongoing data collections, including:  
• Longitudinal Study of Australian Children  
• National Drug Strategy Household Survey  
• The 45 and Up Study  
• Concord Health and Ageing in Men Project  
• Geelong Osteoporosis Study. 
For the purposes of monitoring the modifiable risk factors for arthritis and other 
musculoskeletal conditions , the above 5 data sources are limited in the type of risk factor 
data available and/or their representativeness of the Australian population. For example, the 
Longitudinal Study of Australian Children (LSAC) collects data only in relation to Body 
Mass Index (BMI), exercise and smoking status (for the parents), and the Concord Health 
and Ageing in Men Project (CHAMP) collects data in relation to smoking, alcohol and 
physical activity for men aged 70 and over in the inner west area of Sydney. The longitudinal 
surveys (Longitudinal Study of Australian Children, the 45 and Up, Concord Health and 
Ageing in Men Project) offer the benefit of tracking participants experiencing arthritis and 
other musculoskeletal risk factors over time to explore the development of these conditions. 
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Table 3.1: Assessment of data sources for monitoring modifiable risk factors for arthritis and other 
musculoskeletal conditions  
Key data source Notes Monitoring relevance 
Australian Health 
Survey 
Collects a range of measured and self-reported risk factor data 
Data relevant for arthritis and other musculoskeletal conditions 
Ongoing/regular collection 
Representative national data 
providing comprehensive 
information  
Australian Longitudinal 
Study on Women’s 
Health 
Collects a range of risk factor data 
Data relevant for arthritis and other musculoskeletal conditions 
Ongoing/regular collection 
Representative national data 
providing comprehensive 
information  
Longitudinal Study of 
Australian Children 
Collects a limited range of risk factor data for children and their 
parents 
Data relevant for arthritis and other musculoskeletal conditions 
Ongoing/regular collection 
Representative national data 
providing partial information  
 
National Drug Strategy 
Household Survey 
Collects a limited range of risk factor data for Australians aged 12 
and above 
Data relevant for osteoporosis and rheumatoid arthritis  
Ongoing/regular collection 
Representative national data 
providing partial information  
 
The 45 and Up Study Collects a range of risk factor data 
Data relevant across arthritis and other musculoskeletal conditions 
Ongoing/regular collection 
Representative state data 
providing comprehensive 
information  
Concord Health and 
Ageing in Men Project 
Collects a range of risk factor data 
Data relevant across arthritis and other musculoskeletal conditions 
Ongoing/regular collection 
Representative regional data 
providing comprehensive 
information  
Geelong Osteoporosis 
Study 
Collects a range of risk factor data, including prevalence and 
severity of low bone mineral density 
Data relevant for arthritis and other musculoskeletal conditions, 
particularly osteoporosis 
Ongoing/regular collection 
Representative state data 
providing comprehensive 
information  
Australian Longitudinal 
Study of Ageing (SA) 
Collects a range of risk factor data 
Data relevant for arthritis and other musculoskeletal conditions 
Ongoing/regular collection 
Non-representative state data 
providing partial information  
 
The Tasmanian Older 
Adult Cohort 
Collects a range of risk factor data 
Data relevant for arthritis and other musculoskeletal conditions 
Ongoing/regular collection 
Non-representative state data 
providing partial information  
Florey Adelaide Male 
Ageing Study 
Collects a range of risk factor data 
Data relevant for arthritis and other musculoskeletal conditions 
Ongoing/regular collection 
Non-representative state data 
providing partial information  
Dubbo Osteoporosis 
Epidemiology Study 
Collects a range of risk factor data 
Data relevant for arthritis and other musculoskeletal conditions 
Ongoing/regular collection 
Non-representative state data 
providing partial information  
The Longitudinal Study 
of Indigenous Children 
Collects a limited range of risk factor data for children and parents 
Data relevant for arthritis and other musculoskeletal conditions 
Ongoing/regular collection 
Partial information  
 
North West Adelaide 
Health Study 
Collects a limited range of risk factor data 
Data relevant for arthritis and other musculoskeletal conditions 
No future data collections 
Partial information, non- 
ongoing  
 
Overall assessment of all available data sources Very well developed 
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What information is missing? 
Whilst robust data exist for lifestyle risk factors implicated in arthritis and other 
musculoskeletal conditions (for example, physical activity levels), information is less 
developed in the area of risk factors specifically for back problems (for example, incorrect 
lifting techniques, and occupational factors).  
Currently, there is a lack of nationally representative data on risks for back problems related 
to occupational or sporting/leisure activities. Many of the population may be considered at 
risk of developing back problems through their involvement in a sedentary lifestyle, 
workforce participation or sporting participation. While the Australian Bureau of Statistics 
(ABS) Census and survey products provide broad estimates of the population participating 
in various workforce occupations and sporting activities, this is unlikely to be useful for 
monitoring purposes.  
Injury is also recognised as a risk factor for various forms of arthritis and back problems. For 
example, someone who has injured a joint while playing a sport is more likely to 
subsequently develop arthritis in that joint (AIHW 2008a).  
Examples of injury data that could be used to predict future prevalence of musculoskeletal 
conditions include: 
• The ABS work-related injuries survey, which looks at the causes of the most recent  
work-related injury/illness. The data provide an indication of injuries that can be 
implicated in causing back problems, for example, lifting objects, repetitive movement 
and prolonged standing (ABS 2010). This information is restricted to the most recent 
injury only, has limited information about whether the back problem existed before 
injury and the survey is infrequently conducted. It has therefore not been further 
explored in this report.  
• Information about the numbers of people on the Disability Support Pension and related 
pensions or payments may also provide some information about the outcomes of  
back-related injury or illness in terms of the numbers of people unable to work due to 
these conditions and eligible for government income support (for example, FaHCSIA 
2012 provides high-level data). The usefulness of these data for this purpose may 
warrant further exploration.  
Workplace compensation data (for example, Safe Work Australia 2013) may also provide 
high-level information about one particular component of occupational injury relating to 
back problems (that is, those injuries for which compensation was sought). 
A further data limitation is the lack of information about the link between risk factors and 
the onset of arthritis and other musculoskeletal conditions. This information is largely 
missing and only available from longitudinal studies, which are not always fully 
representative.  
In addition, the data sources available for monitoring risk factors for arthritis and other 
musculoskeletal conditions primarily rely on self-reported information from participants, 
which can be incorrectly recalled and under-reported.  
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3.2 Key question 2—Prevalence 
Why collect information about prevalence? 
Prevalence is a measure of the level of a disease or characteristic in a population at a specific 
time. It is distinct from incidence, which refers to the number of new cases diagnosed in a 
given period. Prevalence is a direct product of incidence and survival; for example, health 
conditions with high incidence and high survival tend to have high prevalence, as is the case 
with arthritis and other musculoskeletal conditions.  
It is important to measure the incidence and prevalence of health conditions because 
knowing how often and how much disease occurs in the population, and in particular 
population groups, plays an important role in preventing and treating illness. The different 
measures can inform aspects of health services planning and delivery (AIHW 2012a). 
For diseases that are mandatorily reported in Australia, incidence statistics can be readily 
obtained, for example, health practitioners’ reporting to state health authorities on cases of 
HIV, tuberculosis and swine flu. In addition, comprehensive and reliable figures can be 
obtained for diseases that have a nationally coordinated and comprehensive register. 
However, for other conditions including arthritis and other musculoskeletal conditions, 
incidence data are not readily available (AIHW 2012a) and so for this report, incidence is not 
discussed further.  
What information is available? 
The most relevant data sources for monitoring the prevalence of arthritis and other 
musculoskeletal conditions are presented in Table 3.2. Our assessment is that the available 
data sources for this information area are ‘Very well developed’, consisting of several 
representative, ongoing data collections, spanning both point-in-time collections and 
longitudinal studies. 
The two main data sources, the AHS and the ALSWH, collect comprehensive information on 
arthritis and other musculoskeletal conditions. This includes professional/doctor-diagnosed 
representative prevalence information for the Australian population, noting that ALSWH is 
representative of women only. These data sources collect information on osteoarthritis, 
rheumatoid arthritis, ‘other arthritis’, gout, osteoporosis, osteopenia, back pain or back 
problems and ‘other musculoskeletal conditions’ and are undertaken on a regular/ongoing 
basis. 
A selection of other state-based data sources provide complementary data, partly due to 
their narrower focus. For example: 
• the 45 and Up Study provides comprehensive information, concentrating on 
osteoarthritis and osteoporosis 
• the Geelong Osteoporosis Study focuses on osteoporosis 
• the Australian Longitudinal Study of Ageing includes both osteoporosis and osteopenia 
• the North West Adelaide Health Study contains data on a range of doctor-diagnosed 
arthritis and other musculoskeletal conditions. 
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Table 3.2: Assessment of data sources for monitoring prevalence of arthritis and other 
musculoskeletal conditions  
Key data source Notes Monitoring relevance 
Australian Health 
Survey 
Collects prevalence estimates for self-reported doctor diagnosed 
osteoarthritis, rheumatoid arthritis, gout, osteoporosis, osteopenia 
and back pain/problems 
Ongoing/regular collection 
Representative national data 
providing comprehensive 
information  
Australian Longitudinal 
Study on Women’s 
Health 
Collects prevalence estimates for self-reported doctor-diagnosed 
osteoporosis, rheumatoid arthritis, ‘other arthritis’, osteoporosis and 
‘other’ as well as self-diagnosed back pain 
Ongoing/regular collection 
Representative national data 
providing comprehensive 
information  
The 45 and Up Study Collects data on whether participants have received treatment for 
osteoarthritis or osteoporosis and whether they have any other 
important illnesses. Also collects data on doctor-diagnosed 
prevalence of osteoarthritis 
Ongoing/regular collection 
Representative state data 
providing comprehensive 
information  
Concord Health and 
Ageing in Men Project 
Collects data on osteoporosis and osteopenia through bone mineral 
testing of the hip and spine 
Ongoing/regular collection 
Representative regional data 
providing partial information  
Geelong Osteoporosis 
Study 
Collects data on prevalence and severity of low bone mineral 
density, which indicates the risk of osteoporosis 
Ongoing/regular collection 
Non-representative regional 
data providing partial 
information  
Australian Longitudinal 
Study of Ageing (SA) 
Collects data on prevalence of osteoporosis and osteopenia 
measured by bone densitometry 
Ongoing/regular collection 
Non-representative state data 
providing partial information  
The Tasmania Older 
Adult Cohort 
Collects data on doctor-diagnosed osteoporosis and rheumatoid 
arthritis and some data on osteoporosis and osteopenia 
Ongoing/regular collection 
Non-representative state data 
providing partial information  
Dubbo Osteoporosis 
Epidemiology Study 
Collects data on minimal trauma fractures, which is particularly 
relevant to osteoporosis 
Ongoing/regular collection 
Non-representative regional 
data providing partial 
information  
North West Adelaide 
Health Study 
Collected data on self-reported doctor-diagnosed arthritis 
(osteoarthritis, rheumatoid arthritis, ‘other’), musculoskeletal pain 
and stiffness (e.g. back pain/stiffness, shoulder pain/stiffness) and 
osteoporosis. Also undertook bone mineral density scans for 
participants aged 50 and above to measure osteoporosis and 
osteopenia  
No future data collections 
Non-representative regional 
data providing partial 
information  
Florey Adelaide Male 
Ageing Study 
Collected data on the prevalence of osteopenia and osteoporosis 
from bone scans 
Ongoing/regular collection 
Non-representative regional 
data providing partial 
information  
Overall assessment of all available data sources Very well developed 
What information is missing? 
Reliance on self-reported cases 
The majority of assessed data sources for measuring prevalence are based on  
doctor-diagnosed cases as self-reported by participants. The validity of self-reported data 
have previously been questioned because they do not always align with data from clinical 
examination and diagnosis (AIHW: Rahman et al. 2005). For example, prevalence estimates 
for osteoporosis are likely to be lower than those based on clinical examination.  
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In addition, respondents may not be familiar with the medical terminology used in the 
survey response options, leading to possible classification and counting inconsistencies.  
Classification inconsistencies 
There may be inconsistencies regarding the classification of the conditions in some surveys, 
which has an impact on the quality of the outputs. The use of rheumatism, a catch-all term 
that means different things to different people, may cause confusion and influence 
participant reporting, particularly affecting estimates of osteoarthritis and rheumatoid 
arthritis.  
In addition, for arthritis and other musculoskeletal conditions, population surveys that 
provide prevalence data are often reported under the broad category of musculoskeletal 
conditions, rather than according to the specific conditions. 
Prevalence of rare and specific conditions 
Due to sample sizes, it is generally not possible to obtain reliable estimates for the prevalence 
of rare and specific conditions, including juvenile idiopathic arthritis. There are potential 
gaps in the prevalence data for this disease. In particular, because of its age-limited 
definition (defined as onset of persistent arthritis before 16 years of age), prevalence 
estimates for juvenile idiopathic arthritis are often based on the number of children with 
arthritis in the population despite the fact that many adults continue to have the condition. 
Prevalence estimates for juvenile idiopathic arthritis are therefore likely to be 
underestimated (AIHW 2008c). 
Coverage  
The AHS does not cover Very remote areas or non-private dwellings such as hotels, motels, 
hostels, hospitals, nursing homes and short-stay caravan parks. It is therefore likely to  
under-represent some groups including those with more severe complications of 
musculoskeletal conditions, and the elderly. 
3.3 Key question 3—Prevention, management and 
treatment 
Why collect information about prevention, management and 
treatment? 
Prevention (of disease or ill health) is described as action to reduce or eliminate the onset, 
causes, complications or recurrence of disease or ill health (AIHW 2008b). There is an 
increasing emphasis on prevention in most health systems, including in Australia, in light of 
the growing burden of chronic diseases, their amenability to preventive health activity and 
the potential to decrease costs.  
A useful framework for understanding prevention, and availability of information about 
prevention, was published by the AIHW in 2009. This report presented the first systematic 
approach to monitoring prevention in relation to cardiovascular disease, diabetes and 
chronic kidney disease, but is relevant across all chronic diseases. It sets out 3 main 
components of prevention—prevention of risk factors (causes), prevention of disease (onset) 
and prevention of progression, complications and recurrence in people with the disease—
noting that, for each of these 3 components, it is important to monitor the outcomes that are 
to be prevented and the prevention services being provided (AIHW 2009).  
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As arthritis and other musculoskeletal conditions cannot generally be cured, management 
and treatment options focus on alleviating symptoms, maximising function and quality of 
life and minimising the impact of disability. This is most commonly achieved through 
medication, in combination with physical and occupational therapy and self-management 
education. In severe cases surgery may be required, for example joint replacement surgery is 
needed for some people with osteoarthritis and rheumatoid arthritis to reduce pain, increase 
joint functionality and improve quality of life (AIHW 2008a).  
Information about the full range of services available for and used by people with 
musculoskeletal conditions would support assessment and evaluation of the quality, 
effectiveness and outcomes of this care. Such an assessment would ideally be undertaken 
with reference to clinical guidelines and agreed models of care (for example, RACGP 2009a, 
2009b, 2009c, 2010 and Arthritis Australia 2014).  
For example, clinical guidelines developed for rheumatoid arthritis, juvenile idiopathic 
arthritis, osteoarthritis and osteoporosis recognise that the first point of contact for the 
patient is usually the GP who can refer to, and coordinate care with, specialists and other 
health professionals (RACGP 2009a, 2009b, 2009c, 2010). Specialists such as rheumatologists 
and orthopaedic surgeons are important for diagnosing rheumatoid arthritis and surgical 
treatment of osteoarthritis. 
The multidisciplinary nature of musculoskeletal management means that information is 
needed about activities in primary health care (which includes most services not provided by 
hospitals and delivered in the community, such as by GPs, pharmacists, community health 
workers, allied health practitioners and practice nurses) and specialist care and the 
interactions between these sectors. In particular, given the continuing and predominant role 
of primary health care (for example, GPs and allied health professionals are generally the 
first point of contact for identification and management of low back pain [Maher et al. 2011]), 
information about GP and allied health activity (such as physiotherapists, occupational 
therapists and podiatrists) is crucial in understanding management of these conditions.  
What information is available? 
The most relevant data sources for monitoring the prevention, management and treatment of 
arthritis and other musculoskeletal conditions  are presented in Table 3.3. Our assessment of 
the suitability of available data sources in this area is that it is ‘Underdeveloped’. This rating 
largely reflects the lack of data to describe comprehensively the full range of services 
currently being accessed by people with musculoskeletal conditions, or to understand the 
level of unmet demand for such services. 
A number of available data sources provide an overview of the management and treatment 
services received by those with arthritis and other musculoskeletal conditions in specific 
selected settings. The main 4 sources are the National Hospital Morbidity Database 
(NHMD), the Australian Health Survey, the Survey of Disability, Ageing and Carers (SDAC) 
and the Australian Orthopaedic Association National Joint Replacement Registry. These 
sources collect data at the national level on a regular or continuing basis. 
Various data sources can be used to describe the results of serious fractures. For example, 
data from the NHMD provide ongoing information about fractures requiring hospitalisation 
or surgery. Hip fracture is a serious and costly osteoporotic fracture suffered by older 
people. The Australian and New Zealand Hip Fracture Registry is being established to 
improve outcomes in hip fracture management. In the future, this registry could provide 
valuable information on the treatment and management of hip fracture (ANZHFR 2014).  
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A range of other data sources provide complementary data to help complete the picture of 
some management and treatment aspects of arthritis and other musculoskeletal conditions, 
including the Bettering the Evaluation and Care of Health (BEACH) Survey of General 
Practice, the Geelong Osteoporosis Study (GOS) and the Australian Rheumatology 
Association Database (ARAD). These sources are limited in their ability to provide 
representative and/or comprehensive data. 
The list of data sources reviewed does not include localised management and treatment 
programs throughout Australia, as they are not readily visible in national information. 
Although these programs may be a valuable resource to sufferers of arthritis and other 
musculoskeletal conditions, routine data collection for monitoring may not be undertaken 
and/or may be difficult to access. An example is the Osteoarthritis Hip and Knee Service 
(OAHKS) in Victoria established to improve management for people with osteoarthritis of 
the hip or knee. The OAHKS stemmed from a localised research project and in 2014 was 
currently operating in 14 hospitals in Victoria. It was also being applied in most other 
Australian states (Box 3.1). 
Box 3.1: The Osteoarthritis Hip and Knee Service 
The primary aims for treatment of established osteoarthritis of the hip and knee are to 
reduce symptoms, prevent disability, maintain or improve quality of life and ensure timely 
access to joint replacement surgery. Before 2006, Victorian patients experienced long 
waiting times to see an orthopaedic surgeon in public hospital outpatient clinics after 
referral by their GP, and even longer waiting times for surgery, if needed. There was also 
variation in the use of the joint replacement surgery categorisation system by surgeons and 
minimal management options offered to patients waiting to see the specialist or for surgery. 
The OAHKS is a multidisciplinary service in which a musculoskeletal coordinator plays a 
key role, along with a prioritisation tool (the hip and knee questionnaire). Following a GP 
referral to an orthopaedic outpatient clinic, a patient completes the prioritisation tool, which 
is used to manage their position on the waiting list. The tool is completed at approximately 
3-monthly intervals during the patient’s time in the system.  
While waiting, patients visit the osteoarthritis hip and knee clinic where they are seen by 
the coordinator who assesses the severity of their condition and need for conservative 
management. The coordinator may also determine if a referral to the surgeon is 
unnecessary because other management options are available, or if they require an urgent 
appointment. 
Most coordinators are physiotherapists and the multidisciplinary team includes GPs, 
waiting list managers, other specialists (rehabilitation, mental health, and general 
medicine), surgeons, allied health and rheumatologists. 
A range of benefits have been achieved through system and workforce changes, including: 
 more appropriate use of limited specialist orthopaedic services, including deferral of 
patients not requiring surgery to appropriate conservative management 
 early comprehensive assessment resulting in fast-tracking to surgical assessment as 
appropriate and/or early referral for conservative management 
 active management of the elective surgery waiting list, including prioritisation to 
match patient need, and 
 improved patient satisfaction (Victorian Department of Health 2013). 
There is, however, limited data on clinical impact and cost-effectiveness. 
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Table 3.3: Assessment of data sources for monitoring prevention, management and treatment of 
arthritis and other musculoskeletal conditions  
Key data source Notes Monitoring relevance 
National Hospital Morbidity 
Database 
Collects data on all hospitalisations (including procedures 
undertaken) related to specific arthritis and other musculoskeletal 
conditions. 
Ongoing/regular collection. 
Representative national 
data providing 
comprehensive information  
AAustralian Health Survey Collects data on certain management undertaken for arthritis and 
osteoporosis. 
Ongoing/regular collection. 
Representative national data 
providing comprehensive 
information  
The Survey of Disability, 
Ageing and Carers 
Collects data on some management aspects for arthritis and related 
disorders, combined back and neck pain and osteoporosis e.g. use 
of aids and appliances, disability support. 
Ongoing/regular collection. 
Representative national data 
providing comprehensive 
information  
Australian Orthopaedic 
Association National Joint 
Replacement Registry 
Collects data on osteoporotic fracture or severe arthritis (primarily 
osteoarthritis) requiring joint replacement surgery. 
Ongoing/regular collection. 
Representative national 
data providing partial 
information  
 
Australian Longitudinal 
Study on Women’s Health 
Collects data on medications for arthritis and backache. 
Ongoing/regular collection. 
Representative national 
data providing partial 
information  
The Bettering the 
Evaluation and Care of 
Health (BEACH) Survey of 
General Practice 
Collects data on a range of treatment and management actions in 
GP settings related to specific arthritis and other musculoskeletal 
conditions. 
Ongoing/regular collection. 
Non-representative 
national data  
 
Geelong Osteoporosis 
Study 
Collects data on use of medications and supplements for those with 
osteoporosis.  
Ongoing/regular collection. 
Non-representative 
regional data  
 
Australian Rheumatology 
Association Database 
Collects data on some treatment aspects for inflammatory arthritis. 
Ongoing/regular collection; has limited coverage of patients. 
Limitations with the use or 
interpretability of the data  
Medicare Benefits Scheme Main source of Australian data on primary care activities; however, 
cannot be traced to specific health conditions. 
Ongoing/regular collection. 
Limitations with the use or 
interpretability of the data  
Pharmaceutical Benefits 
Scheme and Repatriation 
Pharmaceutical Benefits 
Scheme 
Collects data on medication scripts filled; however, cannot be traced 
to specific health conditions except in some specific circumstances. 
Ongoing/regular collection. 
Limitations with the use or 
interpretability of the data  
Voice of Arthritis Social 
Impact Study 
Collected data on satisfaction and perceived level of benefit with 
treatment and management for osteoarthritis and rheumatoid 
arthritis. 
No future data collections. 
Limitations with the use or 
interpretability of the data  
National Non-Admitted 
Patient Emergency 
Department Care 
Database 
Collects data on presentations to emergency departments; however, 
information is not yet available on the health conditions. 
Ongoing/regular collection. 
Limitations with the use or 
interpretability of the data  
Non-admitted patient care 
aggregate national 
minimum data set 
specification 
Collects data on occasions of service provided in selected hospitals 
and emergency departments by clinic type including orthopaedic 
outpatient clinics. 
Ongoing/regular collection. 
Limitations with the use or 
interpretability of the data  
Overall assessment of all available data sources Underdeveloped 
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What information is missing? 
Prevention 
There is very little or no information about the prevention of arthritis and other 
musculoskeletal conditions either at the population or individual level. There is also is very 
little information on primary health care activity of relevance to early detection and ongoing 
effective management of these conditions, other than data collected through the BEACH 
Survey.  
Management and treatment 
While a number of data sources provide an overview of the management and treatment 
services received by those with arthritis and other musculoskeletal conditions, this 
information is incomplete and only available in selected settings. Gaps and limitations 
include: 
• Medicare and the PBS data provide the main national administrative data collections for 
primary and specialist health care in the community. These national ongoing datasets 
provide information about GP, selected allied health care and medical specialist services 
reimbursed under Medicare, and pharmaceuticals attracting a government subsidy. 
They do not cover the whole primary health care sector (for example, not all allied health 
services, specialist services and home modifications and appliances), nor all 
pharmaceuticals (for example, not over-the-counter medications and supplements 
commonly used to manage musculoskeletal conditions). In addition to lack of coverage, 
these data sources cannot generally be used to describe the condition or problem being 
treated because there is no information about health condition in Medicare or 
Pharmaceutical Benefits Scheme (PBS) data.  
• BEACH Survey collects information about reasons for GP visits, problems managed and 
medications prescribed by GPs. However, the survey has limitations due to its 
methodology, quality assurance processes and coverage. Consequently, findings with 
respect to musculoskeletal conditions need to be interpreted with some caution (refer to 
BEACH Data Quality Statement, AIHW forthcoming).  
• Allied health and self-management information. There is currently no national data 
source for the range of allied health care interventions or self-management advice 
recommended for treating musculoskeletal conditions (for example, physiotherapy, 
provision of insoles, taping, physical exercise). 
The limitations about primary health care information for musculoskeletal conditions are 
part of a broader concern with the relative lack of primary health care information in 
Australia. Primary health care has not experienced the same national focus on data capture, 
collation and reporting as other parts of the health system. As a result, there is: 
• little or no information about why someone went to most primary health care 
professionals, what occurred during the consultation, what actions were recommended 
and taken and with what outcome and cost  
• very limited national data (broad counts of patient contacts only) for ambulance,  
aero-medical services and allied health services (including those privately insured) 
• no national data about state-funded community health activity  
• great difficulty in routinely assessing the appropriateness of care with respect to clinical 
guidelines (see for example, Runciman et al. 2012) or effectiveness of care.  
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These limitations mean that it is not possible to describe accurately the full range of services 
currently being accessed by people with musculoskeletal conditions, or to understand the 
level of unmet demand for such services. Several studies suggest various barriers to the use 
of services available to treat musculoskeletal conditions (Box 3.1 and 3.2).  
Box 3.2: Uptake of services for people with severe osteoarthritis 
For people with ‘end stage osteoarthritis’, the use of conservative treatments is thought to 
be low. Management by GPs appears to be the most commonly used option, while options 
such as physiotherapy and rheumatology are used by few people or not at all. Reasons for 
lack of uptake may include: 
 lack of knowledge about other services available by service providers such as GPs 
 financial or other access barriers 
 insufficient capacity in community health settings to meet demand (Osborne et al. 
2006). 
3.4 Key question 4—Health related quality of life 
Why collect information about quality of life? 
A person’s health can be viewed as not merely the absence of disease, but as a combination 
of factors related to their physical, mental and social wellbeing. Quality of life is a broad 
concept used to summarise the wellbeing of individuals and societies. Understanding the 
quality of life of people with musculoskeletal conditions can be useful in comparing it with 
others who do not have these conditions and over time, particularly in relation to how 
quality of life may improve or deteriorate following health interventions, such as responses 
to different medications and treatments.  
Understanding the quality of life of people with arthritis and other musculoskeletal 
conditions is particularly relevant given the long-term nature of these conditions, the 
presence of acute or chronic pain, possible limitations on daily living activities (such as  
self-care and mobility), work or recreational activities, and the established relationship 
between these conditions and psychological distress and mental health problems (see AIHW 
forthcoming). 
While there is no universally agreed definition of what constitutes a ‘good’ quality of life, 
influences include physical health, psychological wellbeing, levels of independence and 
functioning, social support networks, material resources and personal beliefs. Broader 
policies, social inequalities and economic factors can also contribute (AIHW 2012a).  
There are many ways to measure quality of life, including simply asking individuals how 
they feel about their life in general. While such a question is subjective, the answer generally 
reflects a combination of physical, psychological and cultural factors. For example, in the 
ABS 2007 National Survey of Mental Health and Wellbeing, respondents were asked how 
they felt about their life as a whole, taking into account what had happened in the past year 
and what was expected to happen in the future (AIHW 2012a). Details about a range of other 
quality of life measures and their complexities are available in the AIHW publication 
Australia’s health 2012 (AIHW 2012a). 
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What information is available? 
The most relevant data sources for monitoring quality of life among people with arthritis and 
other musculoskeletal conditions  are presented in Table 3.4. We assess data sources in this 
area as ‘Very underdeveloped’, mainly due to a lack of nationally representative data across 
the spectrum of musculoskeletal conditions.  
Table 3.4: Assessment of data sources for monitoring quality of life associated with arthritis and 
other musculoskeletal conditions 
Key data source Notes Monitoring relevance 
Geelong Osteoporosis 
Study 
Collects data on quality of life and mental health in relation to 
osteoporosis  
Ongoing/regular collection 
Non-representative regional 
data  
 
Australian 
Rheumatology 
Association Database 
Collects data on quality of life in relation to inflammatory arthritis 
Ongoing/regular collection; has limited coverage of patients 
Limitations with the use or 
interpretability of the data  
North West Adelaide 
Health Study 
Collects data on general quality of life, pain and ability to participate 
in work and social activities. 
No future data collections 
Non-representative regional 
data providing partial 
information  
The Tasmania Older 
Adult Cohort 
Self-assessed quality of life, level of pain by joint/area (not 
necessarily related to arthritis or musculoskeletal conditions 
Non-representative state data 
providing partial information  
Optimising Patient 
Outcome in Australian 
Rheumatology 
Collects data on quality of life in relation to inflammatory arthritis 
Ongoing/regular collection; has limited coverage of patients 
Limitations with the use or 
interpretability of the data  
Voice of Arthritis Social 
Impact Study 
Non-representative data on impact of arthritis on quality of life, 
physical health, mental health, burden on family or carers and 
ability to participate in social events and paid work 
Data last collected in 2005 and no future data collections planned 
Limitations with the use or 
interpretability of the data  
Overall assessment of all available data sources Very underdeveloped 
What information is missing? 
There are numerous other national data sources asking respondents about their health-
related quality of life where these ratings cannot be linked to a specific health condition (for 
example, the Survey of Disability, Ageing and Carers).  
Several emerging studies and methods could provide information on quality of life for 
specific musculoskeletal conditions. For example, the International Costs and Utilities 
Related to Osteoporotic Fractures Study (ICUROS) is an international patient-based study 
investigating the costs and health effects of osteoporotic fractures, including potential 
differences in quality of life and fracture-related costs. As Australia is one of the participating 
countries in this study, this may provide information on the costs and quality of life 
following hip fracture, vertebral fracture and wrist fracture (ICUROS 2011).  
Numerous state-level programs are collecting and compiling information on quality of life. 
For example, the New South Wales Agency for Clinical Innovation is designing and 
implementing new models of care, such as through the Osteoarthritis Chronic Care Program. 
As part of this program, data will be collected to assess pain, quality of life, psychological 
status and disease-specific functional capacity for people with osteoarthritis (ACI 2014). 
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3.5 Key question 5—Death and disability 
Why collect information about death and disability? 
Arthritis and other musculoskeletal conditions are generally long-term chronic conditions 
associated with pain and disability but rarely death. Information about the disabling impact 
of these conditions is therefore of great interest. Information can be presented either for 
specific groups of musculoskeletal conditions or in summary measure form, as is done in 
‘burden of disease’ studies.  
Burden of disease studies provide a comprehensive summary assessment of the health status 
of Australians. The studies provide information about the health loss due to mortality and 
morbidity arising from all diseases and injuries in Australia, including for specific groups of 
diseases.  
One measure of burden of disease is disability-adjusted life years or DALYs, which quantify 
years of life lost due to premature death, as well as years lived with disability from disease 
and injury. The DALY allows the effects of different diseases and injuries to be compared on 
an equal basis and the contribution of various risk factors to be assessed. One DALY is 1 year 
of life lost due to premature death, prolonged illness or disability, or a combination of these 
factors.  
Further information on DALYs is available from Australia’s health 2012 (AIHW 2012a) and a 
description of how DALYs are calculated in Australia’s health 2010 (AIHW 2010). Further 
information on life expectancy and disability is outlined in Changes in life expectancy and 
disability in Australia 1998 to 2009 (AIHW 2012b). 
What information is available? 
The suitability of available data sources for monitoring the extent death and disability are 
associated with arthritis and other musculoskeletal conditions is rated ‘Well developed’ 
(Table 3.5). The main limitation is the difficulty in quantifying accurately disability related to 
specific musculoskeletal conditions (for example, arthritis compared with other 
musculoskeletal conditions) or the presence of multiple chronic conditions. The Australian 
burden of disease information is also dated (2003), with more recent information expected in 
2015. 
For this aspect of the report the monitoring considers disability, death and burden of disease 
(as a summary measure of these two factors combined). The three data sources available are 
the Survey of Disability, Ageing and Carers; the National Mortality Database, and burden of 
disease studies. 
Mortality data are collected by state/territory registrars of births, deaths and marriages and 
coronial services, coded to the International Classification of Diseases by the ABS, and made 
available to selected users by the Australian Coordinating Registrar under strict privacy 
restrictions. These data are ongoing, comprehensive and of high quality. 
The Global Burden of Disease Study (2010) is the largest systematic attempt to describe the 
global distribution and causes of a wide range of major diseases, injuries and health risk 
factors. This study updates earlier burden of disease information about years of life lost due 
to premature death and years lived with disability from disease and injury.  
The 2010 global study includes estimates for osteoarthritis, rheumatoid arthritis and neck 
and back pain but not for juvenile arthritis or osteoporosis (which is treated as a risk factor), 
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and provides information about how this burden varies across major regions of the world.  
The AIHW is undertaking a project to revise Australia’s burden of disease estimates (last 
produced in 2007 using 2003 data), drawing on the Global Burden of Disease Study 
methodology, and results are expected in late 2015. The Australian study will include 
estimates for Indigenous Australians and sub-national estimates where valid, and will 
provide more detailed information about the burden of selected musculoskeletal conditions 
in the Australian context. 
The Survey of Disability, Ageing and Carers collects data on disability in relation to the 
health conditions causing disability (main disabling condition), other major health conditions 
present, impairment level, activity limitations, employment or participation restriction and 
need for and receipt of assistance. The health conditions covered include osteoporosis, 
combined back and neck pain and arthritis and related disorders. The latest survey, issued in 
2012, is the seventh national survey, following similar surveys in 1981, 1988, 1993, 1998, 2003 
and 2009. 
Table 3.5: Assessment of data sources for monitoring death and disability associated with arthritis 
and other musculoskeletal conditions 
Key data source Notes Monitoring relevance 
Survey of Disability, 
Ageing and Carers 
Collects disability data on the level of impairments, activity 
limitations and participation restrictions for selected musculoskeletal 
conditions (arthritis and related disorders, combined back and neck 
pain and osteoporosis) 
Ongoing/regular collection 
Representative national data 
providing comprehensive 
information  
National Mortality 
Database 
Collects mortality data on arthritis and other musculoskeletal 
conditions, noting that death is not commonly caused by these 
conditions. Certain types of fractures in people with osteoporosis 
can increase the risk of death. Non-steroidal anti-inflammatory 
drugs taken by people with arthritis may also cause premature 
death due to the perforation of stomach ulcers 
Ongoing/regular collection 
Representative national data 
providing comprehensive 
information  
Burden of disease 
studies: Australian 
Burden of Disease 
Study (2003) and 
Australian results of 
Global Burden of 
Disease Study (2010). 
Collects mortality and morbidity data to estimate years of life lost 
due to premature death and years of life lived with disability from 
disease and injury 
Episodic collection 
Representative national data 
providing comprehensive 
information  
Overall assessment of all available data sources Well developed 
What information is missing? 
The key limitation with the national burden of disease information is that it is now becoming 
out of date, the latest Australian study being based on 2003 data. An update by AIHW is 
expected in late 2015. In addition, while information on disability caused by health 
conditions including arthritis and other musculoskeletal conditions is collected through the 
Survey of Disability, Ageing and Carers, other long-term chronic conditions experienced by 
participants may contribute to their assessment, which affects the ability to attribute 
disability directly to arthritis and other musculoskeletal conditions. 
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3.6 Key question 6—Health Expenditure 
Why collect information about health expenditure? 
Measuring health expenditure generally is important to find out: 
 who finances the health system and where the funds are directed  
 how much, on average, is spent on health for each Australian 
 at what rate Australia’s health expenditure is growing each year 
 how fast health costs are rising and how this compares with general inflation 
 how much investment there is in health facilities and equipment. 
Health expenditure for sufferers of arthritis and other musculoskeletal conditions is of 
particular interest because the conditions are highly prevalent, long-term, a significant cause 
of disability and some treatments are expensive. Direct health expenditure in relation to 
arthritis and other musculoskeletal conditions relates to the costs incurred for prevention, 
diagnosis and treatment. Funding for these services comes from government and non-
government sources, including from private health insurance and individuals.  
Other non-health-care costs and indirect costs also accrue to patients, such as travel costs, 
social and economic burden on carers and family, and lost wages. Although these costs are 
not assessed in this report, specific reports do look at these costs, for example, The rising cost 
of musculoskeletal conditions in Australia (Arthritis and Osteoporosis Victoria 2013) and 
Osteoporosis costing all Australians: a new burden of disease analysis – 2012 to 2022 (Watts et al. 
2013). 
What information is available? 
The suitability of available data sources for monitoring expenditure associated with arthritis 
and other musculoskeletal conditions is assessed as ‘Very underdeveloped’ (Table 3.6), due 
to the limited and dated information available on the full amount spent on arthritis and other 
musculoskeletal conditions in Australia.  
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Table 3.6: Assessment of data sources for monitoring health expenditure associated with arthritis 
and other musculoskeletal conditions 
Key data source Notes Monitoring relevance 
The AIHW Disease 
Expenditure Database 
Collects data on expenditure for admitted patient hospital services, 
out-of-hospital medical services and prescription pharmaceuticals 
for the umbrella term ‘musculoskeletal disease’ and broken down by 
categories (osteoarthritis, rheumatoid arthritis, back problems, 
osteoprosis and ‘other’) 
Limitations due to reliance on a range of data sources, particularly 
BEACH Survey data for modelling expenditure on out-of-hospital 
medical services and prescription pharmaceuticals for 
musculoskeletal conditions 
On-going/regular collection 
Representative national data 
providing partial information  
 
Medicare Benefits 
Scheme 
Main source of Australian data on health expenditure but cannot be 
traced to specific health conditions (input to the AIHW Disease 
Expenditure Database) 
Ongoing/regular collection 
Limitations with the use or 
interpretability of the data  
Pharmaceutical Benefits 
Scheme and 
Repatriation 
Pharmaceutical Benefits 
Scheme 
Collects data on expenditure by the government on medication 
scripts filled, noting reason for use must be implied (input to the 
AIHW Disease Expenditure Database) 
Ongoing/regular collection 
Limitations with the use or 
interpretability of the data  
Voice of Arthritis Social 
Impact Study 
Collects data on impact of osteoporosis and rheumatoid arthritis on 
financial position and impact of factors such as medication costs or 
effect of lost wages 
No future data collections 
Limitations with the use or 
interpretability of the data  
Overall assessment of all available data sources Very underdeveloped 
What information is missing? 
The AIHW Disease Expenditure Database contains estimates of expenditure by disease 
category, age group and sex for admitted patient hospital services, out-of-hospital medical 
expenses, prescription pharmaceuticals, optometry and dental services, community mental 
health services and public health cancer screening. This source provides data in relation to 
musculoskeletal disease as an umbrella term and broken down by categories (osteoarthritis, 
rheumatoid arthritis, back problems, osteoprosis and ‘other’).  
While this data source provides a broad picture of the use of health system resources 
classified by disease group, and is a reference source for planners and researchers interested 
in costs and use patterns for particular disease groups, it has several gaps and limitations. In 
particular, it does not cover expenditure on the full range of services used by people with 
musculoskeletal conditions. It does not include expenditure information about  
out-of-hospital services (such as publicly and privately funded allied health, community 
health services, and hospital outpatient services) or expenditure on non-prescription 
pharmaceuticals and supplements commonly used by people with these conditions.  
Because there is no appropriate administrative data source, BEACH Survey data (based on a 
sample of GPs and their encounters with patients) are used in conjunction with other data 
sources (including Medicare and PBS data) to produce proxy estimates for out-of-hospital 
medical services and prescription pharmaceutical expenditure. In addition to reliance on 
survey data to apportion known expenditure, inferences from the AIHW Disease 
Expenditure Database are affected by other limitations, including a lack of information about 
most allied health expenditure and use of non-prescription pharmaceuticals. The overall 
expenditure estimates are therefore affected by these methodological constraints.  
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For these reasons, some caution is required in estimating the direct health expenditure on 
musculoskeletal conditions (in dollar terms), although the distribution of health expenditure 
across the above components (hospital, out-of-hospital and prescription pharmaceuticals) is 
generally regarded as useful information. Similarly, while the methodologies used to 
estimate expenditures for out-of-hospital medical expenses and prescription pharmaceuticals 
have remained unchanged, the current methodology means that time series comparisons for 
expenditure on musculoskeletal conditions should be made with caution. 
Further data collection is also not guaranteed and relies on funding and the availability and 
quality of data sources. For further information about these limitations refer to Health 
expenditure for arthritis and other musculoskeletal conditions (AIHW 2014 forthcoming).  
While studies are commissioned periodically to examine the broader costs to the individual 
or health system (beyond direct health expenditure) (for example Arthritis and Osteoporosis 
Victoria 2013 and Watts et al. 2013), there is no comprehensive, ongoing or nationally 
accepted methodology or data source for this information.  
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4 Discussion 
The purpose of this report is to assess the potential for existing data sources to improve our 
understanding of arthritis and other musculoskeletal conditions. It is not intended to make 
value judgments about the selected data sources per se but to assess their utility to provide 
relevant information for these conditions. The methodological approach presented here can 
potentially be used to assess other data sources for different conditions and diseases. 
For monitoring arthritis and other musculoskeletal conditions, 6 priority information areas 
are identified. This report identifies and assesses the current in-scope data sources available 
to help answer key questions in relation to these 6 priority information areas. Although 
many of the data sources identified were not developed specifically for the purpose of 
musculoskeletal monitoring, the report examines whether the existing data collected (and 
already resourced) could be used for this purpose. 
The key questions for monitoring are: 
1. Risk factors: What proportion of the population experience the modifiable risk factors 
associated with arthritis and other musculoskeletal conditions?  
2. Prevalence: What is the prevalence of arthritis and other musculoskeletal conditions in 
the population? 
3. Prevention, management and treatment: What prevention, management and 
treatment services do the population with arthritis and other musculoskeletal 
conditions receive? 
4. Quality of life: How do arthritis and other musculoskeletal conditions affect an 
individual’s quality of life? 
5. Death and disability: How much death and disability is associated with arthritis and 
other musculoskeletal conditions? 
6. Health expenditure: What is known about expenditure on arthritis and other 
musculoskeletal conditions?  
To determine the suitability of current data collections in Australia, the following steps were 
undertaken: 
Step 1: A stocktake of national and local data sources to identify ‘in-scope’ collections 
(Chapter 2). 
Step 2: A detailed review of all in-scope collections (Chapter 2 and Appendix 1). 
Step 3: An assessment of data sources to determine their relevance to each priority 
information area and their representativeness and completeness for this purpose 
(See Chapter 3). 
Step 4: A comparative assessment of the overall strength of data for each priority 
information area. 
This discussion summarises the outcomes of this comparative assessment (Step 4) in terms of 
the relative strength of available data in each of the 6 areas and outlines several 
opportunities for data development.  
This comparative assessment is based on the number of relevant data sources, their 
individual ratings, and an overall assessment of the relative depth and breadth of data 
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available in each priority information area (spanning both nationally representative 
information and complementary information). To some extent this is an ‘on balance’ 
assessment, which takes into consideration the relative strength of information available 
across all of the priority information areas. 
4.1 Comparative assessment 
Priority information areas with the most developed data 
Risk factors 
Based on assessment of the identified in-scope data collections, Australia has very well 
developed data on most modifiable risk factors, particularly the broad lifestyle risk factors 
implicated for arthritis and other musculoskeletal conditions (for example, physical activity 
levels). However, data are less developed on risk factors for back problems (for example, 
psychosocial health, occupational risks associated with lifting, and other forms of injury). In 
addition, few nationally representative data sources follow populations over time to support 
examination of the link between risk factors and health. Most data sources rely on  
self-reported information, which can be biased or under- or over-reported. Overall, these 
limitations do not lessen the collective value of the data available on risk factors which is 
rated ‘well developed’.  
Overall rating: Very well developed for risk factor data 
The assessment of risk factors information focuses only on factors that are modifiable.  
Non-modifiable risk factors, such as family history, age and sex, can help identify people at 
high risk of developing a disease so that prevention strategies and relevant medical services 
can be planned and located to best effect. However, because modifiable risk factors are 
amenable to change in the population, these were selected as the focus for this report. 
Prevalence 
There is also well developed data to monitor the prevalence of arthritis and other 
musculoskeletal conditions, with the exception of rarer conditions (for example juvenile 
idiopathic arthritis). As with information about risk factors, there are some limitations in that 
many of the key data sources rely on self-reported cases.  
Overall rating: Very well developed for prevalence data 
Many other questions related to prevalence may be answered through access to high-quality 
data. These include how the prevalence of arthritis and other musculoskeletal conditions 
varies according to the living conditions of the population (for example socioeconomic status 
and geographic remoteness), Indigenous status or country of birth, as well as how 
prevalence is changing over time. While not addressed in detail here, as the data tables in 
Appendix A demonstrate, for conditions where prevalence estimates are available it is also 
generally possible to undertake such analysis. 
There are other questions about how many new cases of arthritis or musculoskeletal 
conditions are diagnosed each year (incidence) and at which stage of the disease progression 
they were diagnosed. This type of information is important to assess the effectiveness of 
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preventive health activity (early detection, intervention and early treatment) but is not 
currently available. 
Priority information areas where data requires development 
Death and disability  
Data sources are well developed for producing information about disability associated with 
broad categories of musculoskeletal conditions. The main limitation is the difficulty in 
accurately quantifying disability related to specific musculoskeletal conditions (for example, 
arthritis compared with other musculoskeletal conditions) or where people have multiple 
chronic conditions. Methodology and data are also well developed about burden of disease 
estimates for selected musculoskeletal conditions. However, these are infrequently updated 
and often based on older data at time of release. Therefore, the data in this area are 
considered to be only moderately well developed. 
Overall rating: Well developed for death and disability data 
Prevention, management and treatment 
Data sources to describe prevention, management and treatment are considered to be 
underdeveloped, particularly in relation to prevention activity and the use and 
appropriateness of care provided in primary health care settings. More information is 
available on the type of care provided to admitted hospital patients. However, most of the 
care for arthritis and other musculoskeletal conditions is delivered in GP, community and 
other primary health care settings for which no systematic data is available.  
Identifying and managing the needs of at-risk or asymptomatic people is an important 
aspect of the continuum of care model presented in Figure 1.1 which includes the early 
recognition of symptoms and prompt referral to allied health professionals, specialists and 
education programs. Currently available information does not adequately support the 
development, implementation and evaluation of policies and interventions, in particular 
about early diagnosis and appropriate management.  
This is a problem at various levels of the health system, including nationally, at the 
state/territory level and regionally. For example, Medicare Locals have been asked to see 
and remedy gaps in the needs of their community with respect to primary health care. 
Medicare Locals are a national network of 61 independent primary health care organisations 
working with local primary health care providers to plan health systems at the regional level. 
Overall rating: Underdeveloped for prevention, management and treatment data 
Information on who receives care is part of a broader set of questions about who needs, 
benefits from and demands care versus those who receive it. In asking questions about what 
services a population group receives with respect to musculoskeletal conditions, we are 
interested in what services they need, what services they pursue (demand) and the gap 
between these factors and what they receive. These questions cannot be adequately 
answered using available data. Similarly, it is not possible at present to use routinely 
available data to describe the effectiveness and appropriateness of care for people with 
musculoskeletal conditions.  
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Priority information areas where data are lacking 
Quality of life and health expenditure 
The data sources relating to the impact of arthritis and other musculoskeletal conditions on 
quality of life and health expenditure are very underdeveloped. While many sources 
consider quality of life in general, they are not specific about the impact of arthritis and other 
musculoskeletal conditions.  
Only broad information is available on direct expenditure on arthritis and other 
musculoskeletal conditions, and estimating expenditure on primary health care and 
prescription pharmaceutical is limited by the lack of an appropriate administrative data 
source. In addition, the continuation of reporting on expenditure is not guaranteed. 
Overall rating: Very underdeveloped for quality of life and health expenditure data 
Information about health expenditure is one component of a broader set of questions about 
direct and indirect costs, costs to consumers versus costs to government, and health costs 
versus broader social costs. These aspects have not been investigated in this report. 
Summary of findings 
This report has shown that the data for monitoring arthritis and other musculoskeletal 
conditions in Australia are strongest in the areas of modifiable risk factors and prevalence; 
data are available but require development in the areas of prevention, management and 
treatment and death and disability; and there is a lack of data on quality of life and health 
expenditure (Table 4.1). 
Table 4.1: Assessed data sources: overall rating with respect to each priority information area 
Information area Rating 
Risk factors (modifiable) Very well developed 
Prevalence Very well developed 
Death and disability Well developed 
Prevention, management and treatment Underdeveloped 
Quality of life Very underdeveloped 
Health expenditure Very underdeveloped 
4.2 Future opportunities for data development 
Effective monitoring of arthritis and other musculoskeletal conditions can contribute to 
efforts to relieve some of the burden of sufferers, their carers and the health care system. In 
view of the deficiencies in information about arthritis and other musculoskeletal conditions 
identified in this report, the following section suggests opportunities to improve national 
arthritis and other musculoskeletal conditions monitoring in Australia. 
Data integration and linkage 
By integrating existing data sources, for example through data linkage, it may be possible to 
provide a more complete picture of arthritis and other musculoskeletal conditions.  
Well-developed methods exist, with appropriate protections, that help maximise the utility 
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of existing data, allowing data collected once to be used multiple times. For example, the 
AIHW is one of only two accredited Commonwealth Integrating Authorities. This allows the 
AIHW to undertake data linkage work involving Commonwealth data under enhanced 
security processes and protocols. An example of such linkage could be  linking PBS/RPBS 
data to other treatment and management information, which may provide insights into the 
results of taking certain pharmaceutical medication. At present such data are available only 
from a number of longitudinal studies, which are not always fully representative. 
Improvements in primary health care data 
Considerable limitations apply to primary health care data and information. This is 
particularly relevant because arthritis and other musculoskeletal conditions are 
predominantly managed in the primary health care setting. Improvements in this area are 
part of a broader need for information on primary health care utilisation and outcomes (see 
for example Australia’s health 2014, AIHW forthcoming). 
Data standards 
Monitoring would be enhanced by improved consistency and comparability of data from 
different sources. This could be achieved (as has been done in relation to other conditions, 
for example, cancer) by developing data standards through stakeholder consultation. Such 
standards would include uniform data items, operational definitions and methods of 
reporting to be used as best practice. For example, standardisation is particularly needed in 
surveys that cover prevalence of arthritis and other musculoskeletal conditions.  
Implementation of standard definitions for musculoskeletal conditions would also vastly 
improve the quality of information available (for example, about GP consultations and visits 
to allied health professionals).  
Ongoing nature of collections 
The high rating of data availability achieved for some priority information areas (for 
example, risk factors and prevalence) is due to the comprehensive information available 
from large, nationally representative surveys such as the Australian Health Survey and 
Australian Longitudinal Study on Women’s Health. It is important that these data continue 
to be collected regularly in a comparable way to assess change over time.  
While the AIHW Disease Expenditure Database offers some insight into the estimated cost of 
arthritis and other musculoskeletal conditions, the continuation of this data collection is not 
guaranteed.  
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Appendix A: Data sources template 
The 27 data sources outlined in the Index are described using the following template. 
Full name of the survey or data collection 
Type of data source For example: survey type (registry or administrative) and 
scope (national, state or regional). 
Brief description Brief outline of data source and information relevant for 
monitoring musculoskeletal conditions. 
Purpose(s) Main stated purpose or purposes of the data source. 
Collection methodology Key features of the collection methodology (administrative or 
survey) and data collection method (computer-assisted 
telephone interview, self-completion, administrative). 
Scope (theoretical coverage 
of relevant population) 
Population that is potentially covered. 
Coverage (actual) Actual population covered (response rate). 
Geographic coverage National, state or other. 
Frequency/timing Year(s) in which data have been collected. 
Basic collection count  For example: treatment episodes, separations, etc. 
Size Sample size or number of records in most recent reference 
period. 
Collection management 
organisation 
The organisation chiefly responsible for collecting and 
managing the data. 
Further information A web link with further information. 
P
ri
o
ri
ty
 i
n
fo
rm
a
ti
o
n
 a
re
a
s 
Risk factors Modifiable and not. 
Prevalence and 
incidence  
Prevalence and incidence, injury (osteoporotic fracture) and 
severity. 
Prevention, 
treatment and 
management 
Prevention, treatment and management (in General Practice, 
other primary health care, specialist and hospital settings and 
medication use). 
Quality of life Includes pain, disability, functioning, problems at school, 
work disability, loss of productivity, social participation, and 
mental health, carer impacts. 
Death and 
disability 
Disability, death and burden of disease (as a summary 
measure of these two factors combined). 
Expenditure, 
costs 
To the individual, family members or carers and the health 
system.  
Population 
demographics 
For example: age, sex, location (remoteness and socioeconomic 
status can be generated from location in some cases), 
Indigenous status, marital status. 
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Appendix B: Index of in-scope data 
sources 
1. AIHW Disease Expenditure Database .................................................................................................. 41 
2. Australian Health Survey (AHS), 2011–13 ........................................................................................... 43 
3. Australian Longitudinal Study of Ageing (ALSA) (SA) ..................................................................... 46 
4. The Australian Longitudinal Study on Women’s Health (ALSWH) ................................................ 48 
5. Australian Orthopaedic Association National Joint Replacement Registry .................................... 50 
6. Australian Rheumatology Association Database (ARAD) ................................................................. 52 
7. The Bettering the Evaluation and Care of Health (BEACH) Survey of General Practice .............. 54 
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9. The Concord Health and Ageing in Men Project (CHAMP) ............................................................. 58 
10. Dubbo Osteoporosis Epidemiology Study (DOES) ............................................................................. 60 
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14. Growing up in Australia: The Longitudinal Study of Australian Children (LSAC) ...................... 68 
15. Medicare Benefits Scheme (Medicare) data.......................................................................................... 70 
16. National Drug Strategy Household Survey ......................................................................................... 72 
17. National Hospital Morbidity Database (NHMD) ................................................................................ 74 
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19. National Non-Admitted Patient Emergency Department Care Database (NNAPEDCD) ............ 78 
20. Non-admitted patient care aggregate national minimum data set specification (NMDS) ............ 80 
21. North West Adelaide Health Study (NWAHS) ................................................................................... 82 
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Medicines Initiative (QUMI). ................................................................................................................. 84 
23. Pharmaceutical Benefits Scheme (PBS) and Repatriation Pharmaceutical Benefits Scheme  
(RPBS) data ............................................................................................................................................... 86 
24. The Survey of Disability, Ageing and Carers (SDAC) ........................................................................ 88 
25. The Tasmanian Older Adult Cohort (TASOAC) ................................................................................. 91 
26. Voice of Arthritis Social Impact Study .................................................................................................. 93 
27. The 45 and Up Study ............................................................................................................................... 95 
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Appendix C: In-scope data sources 
1. AIHW Disease Expenditure Database  
Type of data source Derived (national). 
Brief description The AIHW Disease Expenditure Database contains estimates 
of expenditure by disease category for: admitted patient 
hospital services; out-of-hospital medical services; prescription 
pharmaceuticals; optometry and dental services; community 
mental health services, and public health cancer screening.  
The method used to estimate direct health expenditure is 
generally a ‘top–down’ approach (except for hospital admitted 
patient services data) where total expenditure across the 
health system is estimated and then allocated to the relevant 
conditions. This method yields consistency, good coverage, 
and totals that add up to known expenditures, but it is not as 
sensitive or accurate for any specific disease as a detailed 
‘bottom–up’ analysis of actual costs incurred by patients with 
that disease may provide.  
A ‘bottom-up’ approach in allocating disease expenditure 
faces several practical difficulties. For example, expenditure 
such as capital expenses or expenses for general aids and 
medical appliances cannot be attributed to specific conditions. 
There is also a lack of available data to link the broad 
expenditure costs of a particular disease to items such as  
over-the-counter pharmaceuticals and non-admitted patient 
services. 
The Disease Expenditure Database contains a conservative 
estimate of total expenditure and equates to around 70% of 
total recurrent health expenditure. 
Purpose A useful source for planners and researchers interested in the 
costs for particular disease groups. 
Collection methodology Estimates are derived from combining information from the 
NHMD, the National Public Hospitals Establishments 
Database, the Health Expenditure Database, the National 
Hospital Cost Data Collection and the BEACH survey.  
Scope (theoretical coverage 
of relevant population) 
Includes admitted patient hospital services; out-of-hospital 
medical services; prescription pharmaceuticals; optometrical 
and dental services; community mental health services; and 
public health cancer screening.  
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1. AIHW Disease Expenditure Database (Cont.) 
Scope (theoretical coverage 
of relevant population) 
(Cont.) 
It is not possible to allocate all expenditure on health goods 
and services by disease. Expenditure not allocated by disease 
includes: capital expenditure; non‑admitted patient hospital 
services; over‑the‑counter drugs; other health practitioner 
services (except optometry); community health services 
expenditure (except community mental health); expenditure 
on public health programs (except cancer screening 
programs); health administration; health aids and appliances; 
and patient transport (ambulance). 
Coverage (actual) Approximately 70% of total recurrent health expenditure. 
Geographic coverage All states and territories, Australia. 
Frequency/timing 2008-09, 2004-05, 2000-01. Future releases are dependent on the 
availability of data and funding. 
Basic collection count Expenditure (Australian dollars). 
Size Not applicable. 
Collection management 
organisation 
AIHW. 
Further information <http://meteor.aihw.gov.au/content/index.phtml/itemId/51
2599>. 
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Risk factors No data. 
Prevalence 
and incidence 
No data. 
Prevention, 
treatment and 
management 
No data. 
Quality of life No data. 
Death and 
disability 
No data. 
Expenditure, 
costs 
Estimates are available for the following areas of expenditure: 
admitted patient hospital services, out-of-hospital medical 
services, prescription pharmaceuticals. This source provides 
data in relation to musculoskeletal disease as an umbrella term 
and broken down by categories (osteoarthritis, rheumatoid 
arthritis, back problems, osteoprosis and ‘other’). 
Population 
demographics 
Age and sex. 
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2. Australian Health Survey (AHS), 2011–13 
Type of data source Survey (national). 
Brief description The AHS is designed to obtain national information on the 
health status of Australians, their use of health services and 
facilities, and health-related aspects of their lifestyle.  
The AHS has several components: the National Health Survey 
(NHS) together with two new elements - a National Nutrition 
and Physical Activity Survey (NNPAS) and a National Health 
Measures Survey (NHMS). It was not possible for a person to 
be selected in both the NHS and NNPAS.  
The NHS collected information about doctor-diagnosed 
osteoarthritis, rheumatoid arthritis, other arthritis, gout, 
osteoporosis, osteopenia, back pain or back problems and 
other musculoskeletal conditions. Information was gathered 
about whether the condition was current, and whether it had 
lasted or was likely to last for 6 months or more. The NNPAS 
collected information on nutrition and physical activity. 
Following completion of the NHS or NNPAS, respondents 
were invited to participate in the voluntary NHMS. Blood and 
urine samples were collected from people aged 12 and over, 
and for children aged 5-11 urine samples only were requested. 
Relevant to research on musculoskeletal conditions, the blood 
samples were tested for Vitamin D levels. 
The 2011-12 AHS Core comprises a combined data file of both 
the NHS and NNPAS, containing data items that are common 
to both surveys. Information on selected long-term health 
conditions including cardiovascular disease, diabetes and 
kidney disease was collected from both surveys. However, 
information on musculoskeletal conditions was not collected 
from NNPAS. 
Also part of the AHS, the Australian Aboriginal and Torres 
Strait Islander Health Survey (AATSIHS) includes an 
additional representative sample of about 13,000 Aboriginal 
and Torres Strait Islander people. This is a separate collection 
for Aboriginal and Torres Strait Islander people living in 
remote and non-remote areas, including discrete communities. 
The AATSIHS comprises the 2012-13 National Australian 
Aboriginal and Torres Strait Islander Health Survey 
(NATSIHS), the 2012-13 National Aboriginal and Torres Strait 
Islander Nutrition and Physical Activity Survey 
(NATSINPAS) and the National Aboriginal and Torres Strait 
Islander Health Measures Survey (NATSIHMS). Similar to the 
2011-12 AHS Core, the AATSIHS Core comprises a combined 
sample from the NATSIHS and NATSINPAS. 
Purpose To collect information about the health status of Australians, 
their use of health services and health risk factors. 
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2.   Australian Health Survey (AHS), 2011–13 (Cont.) 
Collection methodology Information was collected by trained ABS interviewers, 
through computer-assisted personal interview,  
computer-assisted telephone interview and biomedical testing 
at a pathology collection centre. 
Scope (theoretical coverage 
of relevant population) 
A representative sample of Australians. For the 2011-13 AHS, 
persons in scope of the survey were those identified by an 
adult within each sampled private dwelling as a usual resident 
of that dwelling. Private dwellings are houses, flats, home 
units, caravans, garages, tents and other structures being used 
as a place of residence at the time of the survey. 
For the NHS and NNPAS, Very remote areas were not covered, 
nor were non-private dwellings such as hotels, motels, hostels, 
hospitals, nursing homes and short-stay caravan parks. The 
survey scope does not cover hospitals, nursing homes or 
similar accommodation and so it is likely to under-represent 
those with more severe complications of musculoskeletal 
conditions, and the elderly. 
The NATSIHS was conducted in more than 5,000 private 
dwellings selected in remote and non-remote areas throughout 
Australia, including discrete communities. The sample was 
designed to provide reliable Aboriginal and Torres Strait 
Islander estimates for the whole of Australia, for states and 
territories, for the Torres Strait, and remote and non-remote 
areas to a similar level of accuracy to NATSIHS 2004-05. 
Coverage (actual) The sample was designed so that within each state or territory, 
each person had an equal chance of selection and reliable 
estimates could be produced for each state and territory. 
Geographic coverage All states and territories, Australia. Very remote areas were not 
included in the NHS and NNPAS surveys. 
Frequency/timing The AHS was collected between 2011 and 2013 with results to 
be released progressively from 2012 to 2014. The NHS was 
conducted in 1989–90, 1995, 2001, 2004–05 and 2007–08; the 
NATSIHS survey was conducted in 2004-05 and 2007-08, and 
the National Nutrition Survey was conducted in 1995.  
Basic collection count Persons in households. 
Size The NHS sample comprised 20,426 persons. The NNPAS 
sample comprised 12,153 persons. The AHS Core has a 
combined sample of 25,080 households and 31,837 
respondents aged 2 and over. The NATSIHS sample 
comprised 9,317 persons. The AATSIHS sample size has not 
yet been released but a total sample of 13,000 is expected. 
Collection organisation ABS. 
Further information <http://www.abs.gov.au/ausstats/abs@.nsf/PrimaryMainFe
atures/4363.0.55.001?OpenDocument>. 
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2. Australian Health Survey (AHS), 2011–13 (Cont.) 
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Risk factors Smoking, alcohol use, physical activity (including data from a 
pedometer), long-term health conditions, diet (including 
consumption of milk), BMI, measured Vitamin D levels. 
Prevalence 
and incidence 
Prevalence estimates for doctor-diagnosed osteoarthritis, 
rheumatoid arthritis, gout, osteoporosis, osteopenia, and back 
pain or back problems. 
Prevention, 
treatment and 
management 
If participants answered ‘yes’ to being diagnosed with 
arthritis, osteoporosis or osteopenia, they were asked if they 
took a range of actions for their condition in the last 2 weeks 
e.g. weight/strength/resistance training. Information on 
medications was also collected. 
Participants with osteoporosis/osteopenia were asked 
whether they had had their bone mineral density tested and if 
‘yes’, whether this was performed in the last 2 years. 
Quality of life Participants aged 15 and over in the AHS were asked whether 
in general they felt their health was: excellent, very good, 
good, fair, poor.  
Data was also collected on psychological distress, bodily pain 
and disability status. Note these questions were not asked 
specifically in relation to a musculoskeletal condition. 
Participants were asked about their days away from work or 
study/school due to ill health and restriction in everyday 
activities in relation to their musculoskeletal condition. 
Death and 
disability  
No data. 
Expenditure, 
costs 
No data. 
Population 
demographics 
Age, sex, Indigenous status, place of usual residence, country 
of birth of respondent and year of arrival in Australia, country 
of birth of parents, main language spoken at home, proficiency 
in spoken English, educational qualification, occupation, 
marital status, household composition. 
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3. Australian Longitudinal Study of Ageing (ALSA) (SA) 
Type of data source Longitudinal (state). 
Brief description The ALSA is a cohort study investigating chronic disease, 
health and wellbeing. The study gathers both self-reported 
and bio-medically measured information on people living in 
South Australia. 
The study includes questions on history of low-trauma 
fractures. Bone densitometry scans were carried out in 1992, 
1994 and 2008 in ancillary clinical studies. 
The study gathers information on the following conditions 
(not only doctor-diagnosed): arthritis, osteoporosis, spinal 
problem, slipped/ruptured disc, gout, broken or fractured hip, 
other musculoskeletal problem. 
Purpose(s) The general purpose of the study is to gain an understanding 
of how social, biomedical and environmental factors are 
associated with age-related changes in health and well-being 
of people aged 70 and over.  
Collection methodology At baseline (1992), a comprehensive personal interview and 
assessment of neuropsychological and physiological functions 
was undertaken at each person's home, supplemented by 
questionnaires, biochemistry, and additional clinical studies of 
physical function. Since then a further 11 waves have been 
completed (some consisting of short telephone interviews). 
Data was linked from the Health Insurance Commission on 
Medicare Benefits Scheme and Pharmaceutical Benefits 
Scheme resource use and expenditure data for 439 participants 
for the period 2001-2004.  
Scope (theoretical coverage 
of relevant population) 
The sample was drawn from the South Australian Electoral 
roll. In scope were individuals born before 30 June 1922, and 
their spouses (aged 65 or over in 1992) or co-residents (aged 70 
or over in 1992).  
Coverage (actual) 2,705 individuals drawn from the electoral roll were eligible 
for inclusion, and 1,477 were recruited (55%). For the recruited 
individuals, there were 879 eligible spouses and 24 eligible 
household members, of whom 597 spouses and 13 household 
members were recruited (68%). In full, 2,087 individuals were 
recruited.  
By 2005 there were 349 participants (85.1% of surviving 
participants.) 
Geographic coverage South Australia. 
Frequency/timing Began in 1992 and followed up in 1993, 1994, 1995, 1996, 2000, 
2003, 2005, 2008, 2009, and 2010. The study is continuing 
through a new project titled Resilient ageing and the oldest-old in 
the Australian Longitudinal Study of Ageing. 
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3. Australian Longitudinal Study of Ageing (ALSA) (SA) (Cont.) 
Collection management 
organisation 
The Centre for Ageing Studies, Flinders University. 
Further information <http://www.flinders.edu.au/sabs/fcas/alsa/>. 
Basic collection count  Persons. 
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Risk factors Comorbidity, diet, body mass index, waist circumference, 
smoking, alcohol, exercise, vitamin D in blood sample. 
Prevalence 
and incidence 
Prevalence of osteoporosis and osteopenia measured by bone 
densitometry, history of low-trauma fractures. 
Prevention, 
treatment and 
management 
Overnight hospital stay by condition. 
Quality of life Self-rated health, self-rated quality of life, assistance with daily 
tasks, mobility, psychological - attitudes and views (control, 
morale, self-esteem, metamemory), emotional health. 
Death and 
disability 
No data. 
Expenditure, 
costs 
Limited information. 
Population 
demographics 
Age, sex, area of residence, education level, employment, 
retirement, Indigenous status, nationality, language spoken at 
home, living arrangements. 
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4. The Australian Longitudinal Study on Women’s Health (ALSWH) 
Type of data source Longitudinal survey (national) 
Brief description The ALSWH assesses women’s physical and mental health, as 
well as psychosocial aspects of health (such as  
socio-demographic and lifestyle factors) and their use of health 
services.  
Purpose(s) To provide data about the health of women across the lifespan, 
in order to inform federal and state government health policy. 
Collection methodology In April 1996, women in three age groups - 18-23 (born  
1973-78), 45-50 (born 1946-51), and 70-75 (born 1921-26) were 
selected from the Medicare database, which contains the name 
and address details of all Australian citizens and permanent 
residents. These women were invited to participate and more 
than 40,000 agreed to take part in the project for at least 20 
years. From 1996 to 2011, each age cohort was surveyed about 
once every three years by postal surveys. In 2011, the 1921-26 
cohort began receiving a shortened survey every six months. 
From 2012 onwards the 1973-78 and 1946-51 cohorts have been 
offered the choice of completing the survey online. In 2012-13 
the ALSWH has recruited a new cohort of young women, born 
1989-94 (aged 18-23 at the time of completing the survey), who 
will be surveyed annually using an online survey. 
Data from sub-studies on the ALSWH women include women 
with arthritis and other musculoskeletal conditions. These 
sub-study data include additional questionnaires and assess 
extra variables. Sub-study data are archived by the ALSWH 
and may be made available to external investigators with the 
permission of the original researchers.  
The ALSWH has approval to access a number of national and 
state-based external data sets: 
 Medical Benefit Schedule (MBS) 
 Pharmaceutical Benefits Scheme (PBS) 
 National Death Index 
 Perinatal data collections 
 Cancer registries 
 Admitted patients data collections. 
De-identified data can be linked with the ALSWH data to 
improve researchers’ ability to investigate the health of 
Australian women.  
Sampling from the population was random within each age 
group. Women from rural and remote areas were sampled at 
twice the rate of women in urban areas so that the numbers of 
women living outside major urban areas were large enough to 
allow statistical comparisons with women living in major 
urban areas.  
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4. The Australian Longitudinal Study on Women’s Health (ALSWH) (Cont.) 
Scope (theoretical coverage 
of relevant population) 
Australian women on Medicare database aged 18-23, 45-50,  
70-75 in 1996, and from 2013, women aged 18-23 in 1989-94.  
Coverage (actual) 40,394 women in the original sample in 1996, which is broadly 
representative of the Australian female population. A new 
cohort of at least 14,000 women aged 18-23 is being recruited 
in 2012 and 2013. 
Geographic coverage Australia. 
Frequency/timing Began in 1996 and to continue until at least 2016. 
Basic collection count Persons. 
Size The most recent (6th) surveys had the following survey sizes: 
1973-78 cohort in 2012: 8,008; 1946-51 cohort in 2010: 10,011; 
1921-26 cohort in 2011: 4,055. Since the 1921-26 cohort has 
undergone 6-month surveys at least 3830 participants have 
responded at least once.  
Collection management 
organisation 
The University of Newcastle and the University of 
Queensland, funded by the Department of Health. 
Further information <http://www.alswh.org.au/about/about-the-study>. 
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Risk factors Age, diet, leisure time, physical activity, sitting time, smoking, 
alcohol, other drugs, comorbidities, menopausal status. 
Prevalence 
and incidence 
Self-reported doctor-diagnosed prevalence of osteoarthritis, 
rheumatoid arthritis, ‘other arthritis’, osteoporosis and ‘other’. 
Self-diagnosed back pain. 
Major diagnoses and symptoms (of particular relevance is 
frequency of joint pain and stiffness).  
Fractures in the elderly (likely to be osteoporotic fractures). 
Prevention, 
treatment and 
management 
Visits to GPs, specialists, hospital and other health services.  
The accessibility and level of satisfaction with health services. 
Medications for arthritis and backache.  
Linked data from the PBS and Medicare databases.  
Quality of life Self-reported wellbeing using the Short-Form 36 (SF-36). 
Death and 
disability 
Linked data from National Death Index. 
Linked data from Admitted Patients Data Collections and 
cancer registries. 
Expenditure, 
costs 
Linked data from the Medicare (MBS and PBS) databases. 
Population 
demographics 
Sociodemographic factors (location, country of birth, 
education, employment, family composition, income, how 
women manage on their available income), time use 
(including paid and unpaid work and family roles) and life 
stages and key events (such as childbirth, divorce, death of a 
spouse). Linked data from the perinatal data collections. 
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5. Australian Orthopaedic Association National Joint Replacement Registry 
Type of data source Registry (national). 
Brief description Information on primary and revision joint replacement 
surgery is collected from all hospitals in Australia. 
The information covers patient characteristics, prosthesis type 
and features, method of prosthesis fixation, surgical technique 
used and the reason for joint replacement.  
Revision procedures are matched to primary procedures held 
by the registry. Combined with a careful analysis of the 
timing, type and reasons for revision this is an accurate 
measure of the success or otherwise of a procedure. The 
impact of patient, surgeon and device factors can be 
determined. The registry also monitors mortality rates. This 
information is then used to inform surgeons, other health-care 
professionals, governments, orthopaedic companies and the 
community.  
Purpose(s) The purpose of the registry is to improve and maintain the 
quality of care for individuals receiving joint replacement 
surgery. 
Collection methodology Hospitals provide data on specific registry forms. The paper 
forms are completed in theatre at the time of surgery and are 
returned to the registry each month.  
The registry has extensive internal and external validation 
checks. External validation for data collected from individual 
hospitals is undertaken by comparing it with data provided by 
state and territory health departments.  
Scope (theoretical coverage 
of relevant population) 
All cases of hip, knee, shoulder, elbow, wrist and ankle 
replacement surgery in Australian hospitals.  
Coverage (actual) Close to complete. Patients can opt out by contacting the 
registry co-ordinator. 
Geographic coverage All states and territories, Australia. 
Frequency/timing The ongoing registry was established in 1999 and became fully 
national in mid-2002. 
Basic collection count Procedure. 
Size More than 90,000 people have joint replacement surgery each 
year. 
Collection management 
organisation 
Australian Orthopaedic Association and the Data 
Management & Analysis Centre University of Adelaide which 
is subcontracted by AOA to manage and analyse data.  
Further information <http://www.aoa.org.au/>.  
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5. Australian Orthopaedic Association National Joint Replacement Registry (Cont.) 
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Risk factors No data. 
Prevalence 
and incidence 
Diagnosis – subcaptial fractured neck of femur, major joint 
disease including severe osteoarthritis, rheumatoid arthritis, 
other inflammatory arthritis, osteonecrosis and other joint 
pathology requiring joint replacement surgery.  
Prevention, 
treatment and 
management 
Joint replacement surgery. Reason for both primary and 
revision joint replacement is captured. Through procedure 
linkage the registry is able to identify both best and worst 
practice. 
Quality of life Some data. 
Death and 
disability  
No data. 
Expenditure, 
costs 
Prosthesis cost per procedure. 
Population 
demographics 
Age, gender, laterality, location - detailed address enabling 
SEIFA analysis.  
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6. Australian Rheumatology Association Database (ARAD) 
Type of data source Registry (national). 
Brief description The Australian Rheumatology Association Database (ARAD) 
is a national database developed to follow patients with 
inflammatory arthritis commencing treatment with biological 
disease modifying anti-rheumatic drugs (bDMARDs) 
following consultation with a rheumatologist.  
Included in the database are patients with rheumatoid 
arthritis, juvenile idiopathic arthritis, ankylosing spondylitis 
and psoriatic arthritis who started treatment with bDMARDs. 
The database contains information on participants’ location, 
arthritis history, health status (including quality of life and 
other health conditions), and treatment history (including 
adverse reactions to medication). For some participants the 
database also contains information about arthritis status 
(including tender and swollen joint count) and markers of 
inflammation (including erythrocyte sedimentation rate and 
C-reactive protein and rheumatoid factor status). 
Purpose(s) The aim of the ARAD is to determine effectiveness and safety 
of new biological drugs used to treat inflammatory arthritis. 
Collection methodology The ARAD collects information from patients every 6 months 
by questionnaires. Permission is sought to collect information 
from state and national registries. 
Scope (theoretical coverage 
of relevant population) 
Patients of participating rheumatologists. The study focuses 
on patients with inflammatory arthritis commencing 
treatment with bDMARDs, but also includes patients with 
inflammatory arthritis not taking this class of drugs, included 
as a control group. 
Coverage (actual) As at December 2013, 3,170 participants had completed 
questionnaires and a further 2,112 had agreed to allow 
information to be gathered from state and national registries. 
Out of 342 registered rheumatologists in Australia, 268 are 
participating in ARAD. 
Geographic coverage Australia. 
Frequency/timing The database was started in 2002. 
Basic collection count Person. 
Size As at July 2013, there were more than 5,000 participants and 
more than 30,000 completed questionnaires. 
Collection management 
organisation 
Australian Rheumatology Association, with support from 
Monash University and Cabrini Health.  
Further information <http://www.arad.org.au/Public/Home.aspx>. 
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6. Australian Rheumatology Association Database (ARAD) (Cont.) 
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Risk factors Some information on comorbid conditions. 
Prevalence and 
incidence 
No data. 
Prevention, 
treatment and 
management 
Some information on treatment history, including medication 
use, hospitalisation and adverse drug reactions. 
Quality of life Self-assessed quality of life. 
Death and 
disability 
Some data on disability burden via self-assessed quality of life 
tools. 
Expenditure, 
costs 
Some data on over the counter and complementary medicine 
use. It’s also possible to link to the Pharmaceutical Benefits 
Scheme regarding drug utilisation, and to the Medicare 
Benefits Schedule regarding health services utilisation. 
Population 
demographics 
Patient location. 
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7. The Bettering the Evaluation and Care of Health (BEACH) Survey of General Practice 
Type of data source Survey (national). 
Brief description The BEACH Survey of General Practice is an ongoing survey 
of the clinical activities of GPs. BEACH involves collecting 
details from about 100,000 GP-patient encounters per year, 
from an ever-changing random sample of 1,000 GPs. 
The survey collects data relevant to arthritis and other 
musculoskeletal conditions including the patients’ reasons for 
encounter, problem managed and management actions 
applied to the problems, including pharmacological and  
non-pharmacological treatments prescribed. 
It includes a component where additional questions are asked 
of patients in subsamples of encounters, called the 
Supplementary Analysis of Nominated Data (SAND). 
Different questions are asked in each 5-week recording block. 
The SAND component asks more detailed questions for 
people with specific conditions, in some cases musculoskeletal 
conditions.  
Purpose(s) The BEACH Program continuously collects information about 
the clinical activities in general practice in Australia including: 
• characteristics of GPs 
• characteristics of patients at encounters 
• reasons people seek medical care 
• problems managed.  
For each problem managed the following information is 
gathered: 
• medications prescribed, advised, provided 
• clinical treatments and procedures provided 
• referrals to specialists and allied health services 
• test orders including pathology and imaging. 
Collection methodology Collection is continuous with 20 GPs responding per week. 
Each GP reports on 100 consecutive consultations. All 
consultations are recorded if they result in a management 
action e.g. prescription, referral, etc., including indirect 
consultations such as those by telephone. A paper-based data 
collection system is used. Encounters are weighted according 
to each GP participant’s Medicare claims activity for the year. 
Information is available in annual publications, or in detail 
through data request submissions. 
Scope (theoretical coverage 
of relevant population) 
Random sample of 1,000 GPs annually across Australia, 
selected from Medicare records collecting information on 
almost 100,000 GP patient encounters. In 2009 in Australia, 
there were 25,707 practising primary care practitioners 
(vocationally recognised GPs and other medical practitioners). 
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7. The BEACH Survey of General Practice (Cont.) 
Coverage (actual) There is an incentive for GPs to fill in the survey. Participating 
GPs earn clinical audit points towards their Quality 
Improvement and Continuing Professional Development 
requirements through the Royal Australian College of General 
Practitioners and/or the Australian College of Rural and 
Remote Medicine. 
From April 2011 to March 2012 inclusive, 984 practising GPs 
responded, of 3,644 GPs initially contacted. 
Geographic coverage All states and territories, Australia. 
Frequency/timing The BEACH survey began in 1998 and is undertaken 
continuously with results released annually. 
Basic collection count GP encounters. 
Size From April 2011 to March 2012 inclusive, 984 practising GPs 
responded, of 3,644 GPs initially contacted. Each collects data 
from 100 consecutive consultations. 
Collection management 
organisation 
The Family Medicine Research Centre, University of Sydney. 
Further information <http://sydney.edu.au/medicine/fmrc/beach/>. 
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Risk factors For about 33,000 patients a year, the following measures are 
recorded: height and weight (giving BMI), smoking status, 
and alcohol consumption. For about 3,000 children aged 2–17 
height and weight (giving BMI) are recorded. These risk 
behaviours can be analysed specifically for patients for whom 
arthritis and/or other musculoskeletal problems were 
managed. 
Prevalence 
and incidence 
Estimates of prevalence for all chronic conditions are made on 
the basis of the SAND substudies, sampling usually 8,000—
12,000 in a single year, providing prevalence in patients 
attending a GP, among all patients who attended a GP at least 
once that year, and in the population at large. 
Prevention, 
treatment and 
management 
Treatment and management provided by a GP, including 
medications prescribed, advised, provided; clinical treatments 
and procedures provided; referrals to specialists and allied 
health services, and test orders including pathology and 
imaging. 
Quality of life No data. 
Death and 
disability  
No data. 
Expenditure No data. 
Population 
demographics 
Age, sex, Indigenous status, non-English-speaking 
background (language other than English spoken at home). 
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8. Burden of disease studies: the Australian Burden of Disease Study (2007 – using 2003 
data) and the Australian results of the Global Burden of Disease Study (2010) 
Type of data source Derived (national). 
Brief description Burden of disease studies provide a comprehensive 
assessment of the health of Australians. The studies provide 
information about health loss due to mortality and health loss 
due to disability. 
Burden of disease studies use a metric called the disability-
adjusted life year or DALY to quantify years of life lost due to 
premature death, as well as years of life lived with disability 
from disease and injury.  
Burden of disease analysis provides detailed estimates of the 
burden of mortality and disability for each disease and injury 
category by sex and age. It also assesses the burden 
attributable to major risk factors. 
Purpose(s) To assess and compare the relative impact of different diseases 
and injuries on populations. 
Collection methodology Prevalence, incidence, duration and severity by disease or 
injury are estimated based on any available information, such 
as survey, registry and administrative data. 
Mortality data are drawn from vital registrations.  
Disease weights in the 2010 Global Burden of Disease Study 
were derived from large-scale household surveys across 5 
countries and an internet survey. 
Disease weights used in the 1990 global and 2003 Australian 
studies were assigned based on advice from focus groups of 
health experts. (Disease weights are used in the calculation of 
YLD. They quantify social preferences for different states of 
health). 
This information was brought together to calculate YLL, YLD 
and DALY measures. 
Scope (theoretical coverage 
of relevant population) 
All Australians (including an Indigenous analysis in the 
Australian Burden of Disease Study). 
Coverage (actual) Gaps in the data mean that the coverage is not complete. 
Geographic coverage Australia. 
Frequency/timing The Australian study was published in 1999 and 2007. The 
next study is expected to be published in late 2015. 
The global study was published in 1990, 2000-02, 2004, 2010 
and most recently in 2012-13. 
Basic collection count DALYs, YLLs, YLDs. 
Size Not applicable. 
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8. Burden of disease studies (Cont.) 
Collection management 
organisation 
Australian Burden of Disease Study, next issue: AIHW; 
2007 issue: School of Population Health, University of 
Queensland and AIHW. 
Global Burden of Disease Study: 2010 (Institute for Health 
Metrics and Evaluation). 
1990 WHO (World Health Organization). 
Further information Australian Burden of Disease Study, next issue: 
<http://www.aihw.gov.au/burden-of-disease/>. 
Global Burden of Disease Study: 
<http://www.healthmetricsandevaluation.org/>. 
P
ri
o
ri
ty
 i
n
fo
rm
a
ti
o
n
 a
re
a
s 
Risk factors The 2010 Global Burden of Disease Study contains information 
on occupational risks in relation to arthritis and other 
musculoskeletal conditions. 
Prevalence and 
incidence 
No data. 
Prevention, 
treatment and 
management 
No data. 
Quality of life No data. 
Death and 
disability 
Years of life lost due to premature death, as well as years of 
life lived with disability from disease and injury. 
Specifically includes burden of disease data for arthritis and 
other musculoskeletal conditions (not osteoporosis or juvenile 
arthritis). 
Expenditure, 
costs 
No data. 
Population 
demographics 
2007 Australian Burden of Disease Study: Results presented 
by age, sex, socioeconomic status, remoteness, state or 
territory of residence, Indigenous status. 
2010 Global Burden of Disease Study: results presented by 
age, sex, time (time series available to 1990). 
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9. The Concord Health and Ageing in Men Project (CHAMP) 
Type of data source Longitudinal (regional). 
Brief description The CHAMP is a longitudinal study of ageing in men.  
Doctor-diagnosed osteoporosis is one of the focuses, as is the 
measurement of bone mineral density (BMD). 
The researchers note that men in this study are representative 
of the age and ethnicity of men in the area (inner west Sydney) 
and have similar health characteristics to older men in the 
nationally representative MATeS study. Nevertheless, it is 
likely that frailer men in poor health are less likely to have 
participated in the study, resulting in an underestimation of 
the prevalence of fractures and of low BMD. 
Purpose(s) To examine chronic disease and ageing among older males, 
focusing on cognitive impairment and dementia; falls, 
fractures and osteoporosis; and urinary problems. 
Collection methodology Names were selected from the NSW electoral roll. Men living 
in residential aged care facilities were excluded. 
Self-completed questionnaire and clinical assessments were 
made of physical performance measures, neuropsychological 
testing and medication inventory. Following initial baseline 
assessment, the men were contacted by telephone at  
4-monthly intervals to update data on falls, fractures 
hospitalisation and institutionalisation. 
Scope (theoretical coverage 
of relevant population) 
Men aged 70 or over living in three local government areas 
(Burwood, Canada Bay and Strathfield) in inner west Sydney.  
Coverage (actual) Contact was made with 2,815 eligible men, and 1,511 
participated in the study (54%). An additional 194 eligible men 
volunteered to take part. In total, 1,705 men were recruited in 
the first stage of the study. 
Geographic coverage Three local government areas in inner west Sydney: Burwood, 
Canada Bay and Strathfield. 
Frequency/timing Recruitment and clinical assessments between 2005 and 2007 
with follow-up phone interviews every four months. Five-year 
follow-up examinations were completed in 2013. Funding for a 
7-year follow-up has been obtained. 
Basic collection count  Persons. 
Size 1,705 men recruited in the first stage, with data for 1,367 and 
955 men at the 2- and 5-year follow-ups respectively. 
Collection management 
organisation 
Concord Clinical School, the University of Sydney. 
Further information <http://sydney.edu.au/research/opportunities/opportunitie
s/48>.  
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9. The Concord Health and Ageing in Men Project (CHAMP) (Cont.) 
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Risk factors Smoking, alcohol consumption, physical activity, comorbidity, 
medication use (all prescription and non-prescription 
medications). 
Prevalence 
and incidence 
Prevalence of osteoporosis and osteopenia based on BMD of 
the hip and spine, measured by dual X-ray absorptiometry, 
self-reported minimal trauma fractures over the previous 10 
years. New fractures are identified during 4-monthly phone 
calls. 
Prevention, 
treatment and 
management 
Every 4 months a phone interview collected information on 
falls, fractures (fracture site, date, place of treatment) and 
hospitalisations (reason for admission, date and place of 
admission). 
Community service use in the past 12 months, not specific to 
the musculoskeletal condition (spending at least 1 day in an 
aged care day centre, being visited by Home Care to help with 
personal or household duties, using services of the 
Community and Aged Care packages, or any service to deliver 
or prepare meals at home.) 
Quality of life Self-rated health status. Ability to undertake everyday 
activities. Presence of chronic pain (not specific to a 
musculoskeletal condition) and about knee, hip and back pain. 
Death and 
disability 
No data. 
Expenditure, 
costs 
No data. 
Population 
demographics 
Age, marital status, living arrangements, country of birth, age 
at leaving school, main lifetime occupation (managers and 
professionals versus other), source of income (government 
pension only versus other) and house ownership. 
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10. Dubbo Osteoporosis Epidemiology Study (DOES) 
Type of data source Longitudinal (regional). 
Brief description The DOES tracks low- trauma fractures and mortality. 
Participants receive bone density scans, and efforts are made 
to capture all minimal-trauma fractures in the study 
population. 
Purpose(s) To investigate the progression of osteoporosis in the study 
population. A key focus is the prediction of fractures and  
re-fractures. 
Collection methodology At 2-year intervals, study participants answer questionnaires 
administered by a nurse and clinical measurements are taken 
including bone mineral density. 
For all members of the target population, fractures and 
mortality are monitored. Clinical fractures are ascertained by 
reviewing all radiography reports from the local radiology 
services, ensuring complete ascertainment of all clinical 
osteoporotic fractures (confirmed by personal interview). 
Mortality among residents of Dubbo is monitored, based on 
death certificates. 
Scope (theoretical coverage 
of relevant population) 
The target population included people aged 60 and over, 
living in the Dubbo Local Government Area. The Dubbo 
population is 98.6% Caucasian. 
Coverage (actual) 2,413 women and 1,898 men were in scope, and fracture and 
mortality data were gathered for these people. 1,358 women 
and 854 men participated in the study, providing additional 
information (51%). 
Geographic coverage The Dubbo Local Government Area. 
Frequency/timing Continuous collection of fracture and death data from July 
1989. Questionnaires and clinical measurements at staggered 
2-year intervals. 
Basic collection count  Persons. 
Size Fracture and mortality data for 4,311 people, and within this 
group, questionnaire and clinical measurement data for 2,212 
people.  
Collection management 
organisation 
Garvan Institute of Medical Research. 
Further information The DOES (presentation slides): 
<http://dubbostudy.org/wp-
content/uploads/2012/04/Eisman-DOES-30-3-12.pdf>. 
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10. Dubbo Osteoporosis Epidemiology Study (DOES) (Cont.) 
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Risk factors Smoking, alcohol consumption, body mass index, previous 
fractures and falls, physical activity, calcium intake, 
medication use, postural instability, muscle strength, bone 
density. 
Prevalence 
and incidence 
Minimal-trauma fractures. 
Prevention, 
treatment and 
management 
No data. 
Quality of life No data. 
Death and 
disability 
Mortality data. 
Expenditure, 
costs 
No data. 
Population 
demographics 
Age, sex, reproductive history. 
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11. Florey Adelaide Male Ageing Study (FAMAS) 
Type of data source Longitudinal (regional). 
Brief description The FAMAS is a longitudinal study of men aged 35-80 living 
in the north-west regions of Adelaide. 
The survey gathers information about doctor-diagnosed 
osteoarthritis, rheumatoid arthritis and bone fractures using 
whole body and lumbar spine bone mineral density dual X-ray 
absorptiometry scans (90% of participants agreed to the scan). 
One substudy relates to osteoarthritis, with investigations into 
the bone microenvironment, serum markers of bone turnover, 
joint pain and development of osteoarthritis  
(2005–continuing). 
Comparisons with Census 2001 data showed that participants 
matched the population for most key demographics, although 
younger groups and never married men were under-
represented and elderly participants were over-represented. 
Purpose(s) To examine the reproductive, physical and psychological 
health, and health service utilisation of the ageing male 
Australian population. 
Collection methodology A self-administered questionnaire and a clinical assessment 
measuring a variety of biomedical factors. Baseline clinic visits 
occurred between 2002 and 2005, with follow-up clinics from 
2007 to 2010. Funding is being sought for a third wave of clinic 
visits. Follow-up self-administered questionnaires are 
completed annually. Permission was gathered to link with 
Medicare Benefits Scheme (Medicare) and Pharmaceutical 
Benefits Scheme (PBS) data.  
Participants were also invited to participate in substudies with 
selected collaborators. 
Scope (theoretical coverage 
of relevant population) 
Men aged 35-80 at the time of recruitment, living in western 
and northern Adelaide. Participants were selected at random 
from residential properties listed in the Electronic White 
Pages. Men living in institutions were not in scope. 
Coverage (actual) There were 2,650 eligible subjects and 1,195 participated in 
baseline clinic visits (45.1%). At follow-up, 82.3% of men 
participated in clinic visits, with a further 6.8% responding by 
questionnaire only. As of December 2013, the annual loss to 
follow-up rate is 1.6%. 
Geographic coverage Western Adelaide and northern Adelaide. 
Frequency/timing Baseline clinic visits occurred between 2002 and 2005, with 
follow-up clinics from 2007 to 2010. Funding is being sought 
for a third wave of clinic visits. Follow-up questionnaires are 
completed annually. 
Basic collection count  Persons. 
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11. Florey Adelaide Male Ageing Study (FAMAS) (Cont.) 
Size 1,195 original participants [967 active participants at January 
2014]. 
Collection management 
organisation 
University of Adelaide. 
Further information <http://www.adelaide.edu.au/mailes/>. 
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Risk factors Smoking, physical activity, diet, body mass index, waist and 
hip measurement. 
Prevalence 
and incidence 
Self-report of physician-diagnosed osteoarthritis and 
rheumatoid arthritis. Information about prevalence of 
osteopenia and osteoporosis among men in the study region 
from bone scans. 
Prevention, 
treatment and 
management 
Link with Medicare, PBS. 
Quality of life SF-36. 
Death and 
disability 
Link with National Death Index. 
Expenditure, 
costs 
Link with Medicare, PBS. 
Population 
demographics 
Age, country of birth, income, education level, work status, 
household composition, marital status, residence location. 
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12. Footprints in time: The Longitudinal Study of Indigenous Children (LSIC) 
Type of data source Longitudinal survey (national). 
Brief description The LSIC generates quantitative and qualitative data that can 
be used to provide a better insight into how children’s early 
years affect their development.  
Information can be gathered about children with 
musculoskeletal conditions (such as juvenile arthritis), risk 
factors for musculoskeletal conditions among children, and 
parents or carers with musculoskeletal conditions. 
Purpose(s) The study aims to improve the understanding of, and policy 
response to, the diverse circumstances faced by Aboriginal 
and Torres Strait Islander children, their families and 
communities. 
Collection methodology The study focuses on 11 sites chosen to cover the range of 
socioeconomic and community environments where 
Aboriginal and Torres Strait Islander children live. Agreement 
and approval to participate in the study was sought from 
communities and Elders in these sites before research within 
the communities began. 
Most families in the study were recruited using addresses 
provided by Centrelink and Medicare Australia. Other 
informal means of contact such as word of mouth, local 
knowledge and study promotion were also used to 
supplement the number of children in the study.  
The LSIC surveyed cohorts of Indigenous children aged from 
6 months to 2 years (Baby cohort, or B cohort) and from 3 
years 6 months to 5 years (Child cohort, or K cohort) in Wave 
1. The design allows data covering the first 9 or 10 years of 
Aboriginal and Torres Strait Islander children’s lives to be 
collected in 6 years. 
Children, parents and carers were surveyed using face-to-face 
interviews. Additionally, physical measurements were taken 
of the children. Child care workers and teachers were 
surveyed using self-completed questionnaires.  
Scope (theoretical coverage 
of relevant population) 
The LSIC was designed to sample approximately 150 children 
in each of the 11 sites, providing a sample of up to 1,650 
children. The study selected Indigenous children born 
between December 2003 and November 2004 (K cohort) or 
between December 2006 and November 2007 (B cohort). 
Coverage (actual) There were 1,677 children included in Wave 1, with an 
additional 88 children across the sites added for the second 
wave (non-representative).  
In practice, the K cohort consists of children born in 2003, 2004 
and 2005 and the B cohort consists of children born in 2006, 
2007 and 2008. 
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12. Footprints in time: The Longitudinal Study of Indigenous Children (LSIC) (Cont.) 
Geographic coverage Eleven sites in Australia. No study sites were located in the 
ACT or Tasmania.  
The LSIC sample is not nationally representative; however, it 
sufficiently reflects the distribution of Aboriginal and Torres 
Strait Islander children aged between 0 and 5 years in the 
states and territories and among urban, regional and remote 
areas. 
Frequency/timing The survey began in 2008; surveys are carried out each year.  
Basic collection count Person. 
Size In Wave 5, 1,258 children were included. 
Collection management 
organisation 
Australian Government Department of Social Services. 
Further information <www.dss.gov.au/lsic>. 
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Risk factors BMI, diet, comorbidity, smoking status of parents. 
Prevalence 
and incidence 
Major health conditions for children, parents or carers. Some 
activity restriction data are available. 
Prevention, 
treatment and 
management 
Hospital visits. 
Quality of life Social and emotional status of children. Information from 
child care workers and teachers will shed light on a child’s 
ability to participate in schooling and other activities. 
Death and 
disability 
No data. 
Expenditure, 
costs 
No data. 
Population 
demographics 
Sex, age, Indigenous status, language and cultural practice, 
family structure, housing type, and specifically for adult 
family members: education level and income. 
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13. Geelong Osteoporosis Study (GOS) 
Type of data source Longitudinal survey (regional). 
Brief description The GOS is a prospective cohort study designed to describe the 
health burden of osteoporosis and identify risk factors for 
fragility fracture. The study is set in the Barwon Statistical 
Division, a region in South-Eastern Australia. Biomedical 
measurements including bone mineral density measurements 
are taken from study participants. This allows the estimation of 
the underlying rates of osteoporosis and osteopenia in the 
sample population.  
The study includes a fracture register for the study region. The 
GOS Fracture Grid is an ongoing, comprehensive repository 
documenting incident fractures that have occurred in the 
Barwon Statistical Division.  
Purpose(s) To describe the burden of osteoporosis in the study population 
and to identify risk factors for fracture. 
Collection methodology Paper-based surveys and clinical assessments including bone 
mineral density analysis. Dual-energy X-ray absorptiometry 
provided measures of bone mineral content. Calcaneus 
ultrasound. Blood and urine tests, DNA samples taken. 
Scope (theoretical 
coverage of relevant 
population) 
The study region is described by the ABS as the Barwon 
Statistical Division, situated in South-Eastern Australia. 
Participants were selected from the electoral roll. 
Persons resident for <6 months and those unable to provide 
written informed consent were excluded from the study.  
Coverage (actual) 2,390 women were invited to participate in the female baseline 
study run from 1993 to 1997 and 1,494 accepted. 83% of eligible 
women returned for the 10-year assessment commencing in 
2004. 
3,273 men were invited to participate in the male baseline study 
run from 2001 to 2006 and 1,540 accepted. 81% of eligible men 
returned for the 5-year assessment commencing in 2006. 
No Indigenous Australians participated. 
Geographic coverage The Barwon Statistical Division, a region in South-Eastern 
Australia. 
Frequency/timing Baseline measurements for women began from 1993 and 1997 
and for men between 2001 and 2006. Female participants were 
assessed at the following intervals: 2-year, 4-year, 6-year, 7-year, 
8-year and 10-year follow-up assessments commencing in 1995, 
1998, 2000, 2001, 2002 and 2004 respectively. A further 246 
women aged 20-29 were recruited 2006-8. A 15-year follow-up 
for women, which began in 2011, is soon to be completed. Male 
participants were assessed at a 5-year and 6-year interval, 
commencing in 2006 and 2007 respectively. 
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13. Geelong Osteoporosis Study (GOS) (Cont.) 
Basic collection count Persons. 
Size 881 women returned for the 10-year assessment commencing in 
2004. 978 men retuned for the 5-year assessment commencing in 
2006. 
Collection management 
organisation 
Epidemiology Unit for Healthy Ageing, part of the IMPACT 
Strategic Research Centre (Deakin University). 
Further information <http://www.barwonhealth.org.au/epidemiology-unit-for-
musculoskeletal-and-metabolic-disorders-epi-ummd>. 
<http://www.deakin.edu.au/research/documents/pasco.pdf> 
<http://www.deakin.edu.au/research/src/impact/>. 
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Risk factors BMI, sun exposure, comorbidities, medication use, physical 
activity, alcohol and tobacco use, family history of fractures, 
diet. Prevalence and severity of low bone mineral density 
among study participants. 
Prevalence 
and incidence 
Prevalence and severity of osteoporosis and osteopenia based 
on measured bone mineral density among study participants. 
Fracture occurrence. 
Prevention, 
treatment and 
management 
Use of medications and supplements. 
Quality of life Self-reported quality of life, mobility, use of walking aid, mental 
health, pain. 
Death and 
disability  
No data. 
Expenditure, 
costs 
No data. 
Population 
demographics 
Age, sex, socioeconomic status of area of residence, education, 
marital status, occupation, employment status, country of birth, 
ethnicity. 
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14. Growing up in Australia: The Longitudinal Study of Australian Children (LSAC) 
Type of data source Longitudinal survey (national). 
Brief description The LSAC is a longitudinal survey investigating the 
contribution of children's social, economic and cultural 
environments to their adjustment and wellbeing.  
Information can be gathered about children with 
musculoskeletal conditions (such as juvenile arthritis), risk 
factors for musculoskeletal conditions among children, and 
parents or carers with musculoskeletal conditions. 
Purpose(s) To identify policy opportunities for improving support for 
children and their families and for early intervention and 
prevention strategies. 
Collection methodology The study began in 2004 with two cohorts - families with 4-5 
year old children and families with 0-1 year old infants. 
Children, parents, carers, child care workers and teachers were 
surveyed. A range of survey methods were used, such as face-
to-face interviews, self-completed questionnaires, physical 
measurements of children, audio computer-assisted self 
interviews and computer-assisted telephone interviews. 
The sample was selected from Medicare Australia’s enrolment 
database. 
Scope (theoretical coverage 
of relevant population) 
Families of 18,800 selected children received letters of 
invitation to take part in the study. 
Coverage (actual) The final response to the recruitment of children was 54% of 
those families who were sent the initial letter (10,090 children), 
with participants representative of Australia’s children 
population. 
Geographic coverage Australia. 
Frequency/timing From 2004, the recruited families have been interviewed every 
2 years. In addition, mail-out questionnaires were sent to 
families in 2005, 2007 and 2009.  
Basic collection count Persons. 
Size The 2010 wave collected data on 8,405 children. 
Collection management 
organisation 
The LSAC is conducted by the Australian Government 
Department of Social Services, the Australian Institute of 
Family Studies and the Australian Bureau of Statistics.  
The Wave 1 data collection was undertaken by Colmar-
Brunton Social Research and I-view/NCS Pearson, private 
social research companies. Data collection for waves 2, 3 and 4 
was undertaken by the Australian Bureau of Statistics. 
Further information <http://www.growingupinaustralia.gov.au/index.html>. 
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14. Growing up in Australia: The Longitudinal Study of Australian Children (LSAC) 
(Cont.) 
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Risk factors BMI, exercise, smoking status of parents.  
Prevalence and 
incidence 
Diagnosed conditions lasting 6 months or more for children or 
parents. The following information is gathered about the 
severity of health limitations, which is relevant when a 
musculoskeletal condition is present: 
 limited use of arms or fingers 
 difficulty gripping 
 limited use of legs and feet 
 restrictions in everyday activities 
 chronic pain. 
Prevention, 
treatment and 
management 
Hospital stays. 
Quality of life Social and emotional status of children. Time use data and 
information from child care workers and teachers will shed 
light on a child’s ability to participate in schooling and other 
activities.  
Death and 
disability 
No data. 
Expenditure, 
costs 
No data. 
Population 
demographics 
Age, sex, country of birth, ethnicity, language spoken at home, 
Indigenous status, family structure, housing type, and 
specifically for parents and carers: education level and income. 
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15. Medicare Benefits Scheme (Medicare) data 
Type of data source Administrative (national). 
Brief description Medicare is Australia’s universal health insurance scheme. 
Medicare provides access to: 
 free treatment as a public patient in a public hospital 
 free or subsidised treatment by practitioners such as 
doctors, including specialists, participating optometrists or 
dentists (specified services only). 
All Australian residents and overseas visitors covered by a 
reciprocal health-care agreement requiring immediate medical 
attention are eligible for subsided treatment under Medicare. 
The associated Medicare data set comprises information on all 
medical services claimed through Medicare. These services 
include visits to a GP, certain specialists and allied health 
professionals and hospital visits by a private patient in a 
public or private hospital. There is limited information about 
why a service was used. 
Medicare records include only services that are claimed for 
Medicare benefits and for which claims have been processed 
(they do not include services provided under the Department 
of Veterans Affairs National Treatment Account). 
Medicare data excludes: 
 services that have been provided in public hospitals to 
public patients 
 services provided in outpatient or emergency departments 
of public hospitals. 
These are covered in separate hospitals data. 
Purpose(s) The purpose of Medicare is to provide people with subsidised 
medical services. Medicare data provides broad information 
on the type of services used and the benefit paid by Medicare 
for the service. 
Collection methodology Providers or patients submit claims for payment reflecting 
Medicare activity.  
Scope (theoretical coverage 
of relevant population) 
All Australian residents and eligible overseas visitors. 
Coverage (actual) Information will be missing if individuals or doctors fail to 
lodge claim information. This should be a rare occurrence, as 
there is a financial incentive to do so. 
Geographic coverage All states and territories, Australia. 
Frequency/timing Ongoing. 
Basic collection count Number of subsidised medical services. 
Size Not applicable. 
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15. Medicare Benefits Scheme (Medicare) data (Cont.) 
Collection management 
organisation 
Medicare is managed by the Department of Health and 
administered by the Department of Human Services. 
Further information <http://www.medicareaustralia.gov.au/provider/medicare/
index.jsp>. 
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Risk factors No data. 
Prevalence 
and incidence 
No data. 
Prevention, 
treatment and 
management 
Management by GPs, private hospitals and some allied health 
professionals (although information on why the service was 
used is limited). Location of practice. 
Quality of life No data. 
Death and 
disability 
No data. 
Expenditure, 
costs 
Expenditure by Medicare on services provided by GPs, private 
hospitals and some allied health professionals and cost of 
services.  
Population 
demographics 
Sex, age, usual residence of patient (various levels such as 
SLA, RRMA). Indigenous status. 
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16. National Drug Strategy Household Survey 
Type of data source Survey (National). 
Brief description The National Drug Strategy Household Survey provides 
representative cross-sectional data on alcohol, tobacco and 
other drug use in Australia. The data relevant to 
musculoskeletal conditions include smoking and alcohol 
consumption behaviours. 
The survey gathers information about health conditions, but 
does not include any specific questions about the presence of 
musculoskeletal conditions (respondents may write it in 
‘other’). 
Purpose(s) This survey is designed to collect self-reported information on 
drug-related attitudes, behaviours, consumption and health. 
Collection methodology Self-completion paper-based survey. Interviewers make 
contact with a household, carry out a respondent selection 
procedure, leave the survey form to be completed and then 
return to collect it at an agreed time. Before the 2010 survey 
there was an additional computer-assisted telephone 
interview component and from 1985-2001 face to face 
interviews were conducted.  
Scope (theoretical coverage 
of relevant population) 
From 2004 the sample has covered Australians aged 12 and 
over (prior to then it captured age 14 and over). The design of 
the survey excludes those who live in non-private dwellings, 
are homeless or live in institutions or on military bases. 
Coverage (actual) For the 2010 survey, contact was made with 52,690 in-scope 
households, of which 26,648 questionnaires were categorised 
as being complete and useable, representing a response rate of 
50.6%. 
Geographic coverage Australia. 
Frequency/timing Results from the 2013 survey will be released in mid- to late 
2014. Previous surveys were conducted in 1985, 1988, 1991, 
1993, 1995, 1998, 2001, 2004, 2007 and 2010.  
Basic collection count Persons. 
Size In 2010, 26,648 respondents. 
Collection management 
organisation 
AIHW. 
Further information <http://www.aihw.gov.au/national-drugs-strategy-
household-surveys/>. 
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16. National Drug Strategy Household Survey (Cont.) 
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Risk factors Smoking and alcohol consumption. 
Prevalence 
and incidence 
Limited data, not suitable for musculoskeletal monitoring. 
Prevention, 
treatment and 
management 
No data. 
Quality of life No data. 
Death and 
disability 
No data. 
Expenditure, 
costs 
No data. 
Population 
demographics 
Age, sex, location (remoteness and SEIFA), Indigenous status, 
marital status, education, household composition, 
employment status. 
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17. National Hospital Morbidity Database (NHMD) 
Type of data source Administrative (national). 
Brief description The NHMD is a compilation of episode-level records from 
admitted patient morbidity data collection systems in 
Australian hospitals.  
Purpose(s) To provide information on admitted patient care, such as 
demographic, administrative and length of stay data, as well 
as data on the diagnoses of the patients, the procedures they 
underwent in hospital and external causes of injury and 
poisoning. 
Collection methodology The data supplied are based on the National Minimum Data 
Set for admitted patient care. Data are supplied to the AIHW 
by state and territory health authorities under the terms of the 
National Health Information Agreement.  
Scope (theoretical coverage 
of relevant population) 
The NHMD is a comprehensive data set that has records for all 
episodes of admitted patient care from essentially all public 
and private hospitals in Australia. 
Coverage (actual) For 2011–12, almost all public hospitals provided data for the 
NHMD. 
Geographic coverage All states and territories, Australia. 
Frequency/timing Annually from 1993-94. 
Basic collection count Number of separations.  
A separation is an episode of care, which can be a total 
hospital stay (from admission to discharge, transfer or death), 
or a portion of a hospital stay beginning or ending in a change 
of type of care (for example, from acute to rehabilitation). 
Size There were 9.3 million separations recorded in the NHMD in 
2011-12. 
Collection management 
organisation 
The NHMD is compiled by the AIHW from data supplied by 
the state and territory health authorities under the terms of the 
National Health Information Agreement. 
Further information <http://meteor.aihw.gov.au/content/index.phtml/itemId/52
9483>.  
  
 72 Data sources for monitoring arthritis and other musculoskeletal conditions 
17. National Hospital Morbidity Database (NHMD) (Cont.) 
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Risk factors Smoking rates are recorded for people who are hospitalised. 
Additional diagnoses are recorded, if the condition or 
complaint could potentially affect patient management.  
Prevalence 
and incidence 
Fracture data are available; however, although the external 
cause code provides some information about factors 
contributing to the injury, it is not always possible to 
distinguish between low-trauma (osteoporotic) and  
high-trauma fractures. 
Prevention, 
treatment and 
management 
Hospital treatment and procedures, area of hospital (statistical 
local area (SLA) level). 
Quality of life No data. 
Death and 
disability 
No data. 
Expenditure, 
costs 
No data. 
Population 
demographics 
Sex, age, Indigenous status, area of usual residence (SLA 
level). 
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18. National Mortality Database (NMD) 
Type of data source Administrative (national). 
Brief description The NMD contains information pertaining to deaths registered 
in Australia since 1964. Information is provided on the 
underlying cause of death (the disease or condition leading 
directly to death). From 1997 data are available on the 
associated causes of death (diseases or conditions other than 
the underlying cause that contributed to the death). 
Purpose(s) The NMD is used by the AIHW to produce population-level 
analyses for: monitoring and surveillance of mortality due to 
specific chronic diseases (or all causes combined); burden of 
disease research; and to inform Closing the Gap and other 
COAG indicators. It is also used to fulfil data requests for 
external researchers. 
Collection methodology Deaths are registered by the registrars of Births, Deaths and 
Marriages in each state and territory. Death registration is 
compulsory. The cause of death is certified by the medical 
practitioner or the coroner and coded using the International 
Classification of Diseases. Demographic and administrative 
information about the deceased is collected on the Death 
Information Form, filled out by the deceased’s next of kin in 
conjunction with the funeral director. 
Scope (theoretical coverage 
of relevant population) 
The Australian Bureau of Statistics (ABS) Death Registrations 
collection includes all deaths that occurred and were 
registered in Australia, including deaths of persons whose 
place of usual residence was overseas. Deaths of Australian 
residents that occurred outside Australia may be registered by 
individual registrars, but are not included in ABS death 
statistics. 
Coverage (actual) While all deaths are legally required to be registered some 
cases may not be registered for an extended time, if at all. 
Geographic coverage Australia. 
Frequency/timing The ABS issues summaries of cause of death annually and the 
AIHW updates the NMD once these data become available.  
Basic collection count Number of deaths. 
Size There were 137,854 deaths registered in 2007. 
Collection management 
organisation 
The information is provided to the ABS for coding the cause of 
death and compiling into aggregate statistics. The AIHW 
manages the NMD. 
Further information Quality declaration: 
<http://www.abs.gov.au/Ausstats/abs@.nsf/0/D4A300EE1E
04AA43CA2576E800156A24?OpenDocument>. 
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18. National Mortality Database (NMD) (Cont.) 
P
ri
o
ri
ty
 i
n
fo
rm
a
ti
o
n
 a
re
a
s 
Risk factors For people who die with a musculoskeletal condition as the 
underlying or associated cause of death, information is 
provided on other contributing factors in the death.  
Prevalence 
and incidence 
No data.  
Prevention, 
treatment and 
management 
No data. 
Quality of life No data. 
Death and 
disability 
Mortality burden. 
Expenditure, 
costs 
No data. 
Population 
demographics 
Sex, age at death, area of usual residence (SLA level), 
remoteness of usual residence, Indigenous status, country of 
birth. 
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19. National Non-Admitted Patient Emergency Department Care Database 
(NNAPEDCD) 
Type of data source Administrative (national). 
Brief description The NNAPEDCD is a compilation of episode-level data for 
emergency department presentations in selected public 
hospitals.  
Purpose(s) To provide information on patient care for emergency 
department presentations in public hospitals. 
Collection methodology State and territory health authorities provide the data to the 
AIHW for national collation, on a quarterly basis within 1 
month of the end of a reporting period and an annual basis 
within 3 months of the reporting period. 
Scope (theoretical coverage 
of relevant population) 
The scope of the NNAPEDCD is non-admitted patients 
registered for care in emergency departments in selected 
public hospitals that are classified as either peer group A or B 
in the Australian hospital statistics publication from the 
preceding financial year (principal referral and specialist 
women’s and children’s hospitals and large hospitals). 
Some states and territories also provide data for public 
hospitals that were classified in peer groups other than A or B 
(see Australian Hospital Statistics 2011-12 for more 
information).  
Before 1 January 2012, the data collection did not include care 
provided to admit patients in emergency departments. From 1 
January 2012, all care provided to patients treated in 
emergency departments is in scope for this collection. Care is 
included until the patient is recorded as having physically 
departed the emergency department, regardless of whether 
they have been admitted. However, care provided to patients 
admitted to ‘short stay units’ is not included. 
Coverage (actual) For 2012-13 the proportion of occasions of service in 
emergency departments reported to the NNAPEDCD was 
estimated to account for 84% of all emergency occasions of 
service in public hospitals. 
Geographic coverage National. 
Frequency/timing Financial year, from 2003-04 onwards. 
Basic collection count Episodes of care. 
Size Not applicable. 
Collection management 
organisation 
The database was assembled by the AIHW from data supplied 
by the state and territory health authorities. 
Further information <http://meteor.aihw.gov.au/content/index.phtml/itemId/54
6749>.  
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19. National Non-Admitted Patient Emergency Department Care Database (Cont.) 
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Risk factors No data. 
Prevalence 
and incidence 
Some information on diagnosis will be available from 2013-14 
onwards. 
Prevention, 
treatment and 
management 
When diagnosis information becomes available, this database 
may provide information on episodes of care for 
musculoskeletal conditions provided in emergency 
departments. 
Quality of life No data. 
Death and 
disability 
No data. 
Expenditure, 
costs 
No data. 
Population 
demographics 
Age, sex, Indigenous status, area of usual residence. The 
quality of the data reported for Indigenous status has not been 
formally assessed; therefore, caution should be exercised when 
interpreting these data. 
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20. Non-admitted patient care aggregate national minimum data set specification (NMD) 
Type of data source Administrative (national). 
Brief description The non-admitted patient care aggregate NMD contains data 
on non-admitted patient service events involving non-
admitted patients in activity-based funded hospitals. The 
NMD scope includes all arrangements made to deliver non-
admitted patient service events to non-admitted patients: 
 irrespective of location (includes on- and off-campus) 
 whose treatment has been funded through the hospital, 
regardless of the funding source. In particular, Department 
of Veterans’ Affairs, compensable and other patients 
funded through the hospital (including Medicare ineligible 
patients) are included 
 regardless of setting or mode. 
Excluded from the NMDS scope are all services covered by: 
 the Admitted patient care NMDS 
 the Admitted patient mental health care NMDS,  
 the Non-admitted patient emergency department care 
NMDS, e.g. all non-admitted services provided to admitted 
patients are excluded 
 service events which deliver non-clinical care, e.g. activities 
such as home cleaning, meals on wheels or home 
maintenance. 
Information on diagnosis isn’t available in this data set. 
Purpose(s) The non-admitted patient care aggregate NMDS captures 
instances of service provision from the patient’s point of view.  
Collection methodology Hospital records are generated when non-admitted patients 
receive outpatient services. 
Scope (theoretical coverage 
of relevant population) 
All arrangements made to deliver non-admitted patient 
service events to non-admitted patients. 
Coverage (actual) Yet to be determined. Data for the first year not yet finalised. 
Geographic coverage National. 
Frequency/timing 2013-14 onwards. Replaces the Outpatient care NMDS 
covering 2007-08 to 2012-13. 
Basic collection count Non-admitted patient service event. 
Size Yet to be determined. Data for the first year not yet finalised. 
Collection management 
organisation 
The database is being assembled by the AIHW from data 
supplied by the state and territory health authorities. 
Further information <http://meteor.aihw.gov.au/content/index.phtml/itemId/50
8306>. 
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20. Non-admitted patient care aggregate national minimum data set specification 
(NMDS) (Cont.) 
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Risk factors No data. 
Prevalence and 
incidence 
No data. 
Prevention, 
treatment and 
management 
Hospital outpatient services such as orthopaedic services, but 
these services are not specific to musculoskeletal conditions. 
Quality of life No data. 
Death and 
disability 
No data. 
Expenditure, 
costs 
No data. 
Population 
demographics 
No data. 
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21. North West Adelaide Health Study (NWAHS) 
Type of data source Longitudinal survey (regional). 
Brief description The NWAHS is a longitudinal cohort study investigating chronic 
disease and health-related risk factors, from both self-reported and 
biomedically measured information for people living in the north-
western region of Adelaide. 
Information about the prevalence of arthritis (osteoarthritis, 
rheumatoid arthritis or other arthritis), osteoporosis and 
musculoskeletal pain and stiffness was gathered in the second and 
third stages of the study. 
Information about prevalence of gout was gathered in the third 
stage of the study. In the second stage of the study, participants 
aged 50 and over were offered a dual-energy X-ray absorptiometry 
scan to measure their bone density. 
Purpose(s) To make a comprehensive health assessment of the community of 
north-west Adelaide in order to inform health policy. 
Collection 
methodology 
Telephone and self-complete questionnaires and biomedical 
measurements. Consent was obtained from participants to link to 
Medicare Benefits Scheme (MBS) and Pharmaceutical Benefits 
Scheme (PBS) records. 
Scope (theoretical 
coverage of relevant 
population) 
Households in north-west Adelaide were chosen at random from 
the electronic White Pages. One member of each household over 
the age of 18 was chosen at random. 
Coverage (actual) 4,056 adults attended the Stage 1 clinic visit, between November 
1999 and July 2003; 3206 of the cohort returned for the Stage 2 
clinic visit between May 2004 and February 2006, and 2,487 of the 
cohort returned for the Stage 3 clinic visit between June 2008 and 
August 2010. 
Geographic coverage The north-western region of Adelaide, stretching from the suburbs 
Glenelg to Gawler. 
Frequency/timing Stage 1 was run between 1999 and 2003, Stage 2 between 2004 and 
2006 and Stage 3 between 2008 and 2010. Additional telephone 
surveys were run in 2002 and 2007. 
Basic collection count Persons. 
Size The original cohort was 4,056 people; 2,487 of these participated in 
the most recent clinic visit, between June 2008 and August 2010. 
Collection 
management 
organisation 
The NWAHS is led by the University of Adelaide, in collaboration 
with the University of South Australia, SA Health, the Institute of 
Medical and Veterinary Science, The Queen Elizabeth Hospital and 
the Lyell McEwin Hospital. 
Further information <http://www.nwadelaidehealthstudy.org/project_overview.asp>. 
<http://health.adelaide.edu.au/pros/data/nwahs/>. 
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21. North West Adelaide Health Study (NWAHS) (Cont.) 
P
ri
o
ri
ty
 i
n
fo
rm
a
ti
o
n
 a
re
a
s 
Risk factors Smoking, alcohol consumption, obesity (BMI, waist and hip 
measurements), comorbidity, diet, physical activity, family history 
of osteoporosis, sun exposure (relevant for vitamin D). 
Prevalence and 
incidence 
Prevalence of self-reported doctor-diagnosed arthritis, osteoporosis 
and gout. Prevalence of self-reported musculoskeletal pain and 
stiffness. Self-reported occurrence of minimal trauma fracture.  
Prevalence of osteoporosis and osteopenia, derived from bone 
density measurements for participants aged over 50. 
Measures of severity: grip strength, level of pain, level of stiffness 
and ache in joints, level of activity limitation due to joint problems. 
Prevention, 
treatment and 
management 
Hip and knee replacement. Use of health services and prescription 
medication from the linked MBS and PBS databases. 
Quality of life General quality of life, perception of general health, physical 
functioning, bodily pain, ability to participate in work and social 
activities (SF-36). 
Death and 
disability 
No data. 
Expenditure, 
costs 
MBS and PBS costs. 
Population 
demographics 
Age, sex, postcode, country of birth, Indigenous status, living 
arrangement, marital status, number of children, occupation, 
income, education level 
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22. Optimising Patient outcome in Australian rheumatoLogy (OPAL) – Quality Use of 
Medicines Initiative (QUMI). 
Type of data source The OPAL registry is a multi-centre, cross-sectional, 
retrospective, non-interventional study.   
Brief description In 2009, in consultation with Australian rheumatologists, 
Roche established a point-of-care disease management and 
audit software package, initially specific to rheumatoid 
arthritis (RA), with the intent of addressing unanswered 
relevant research questions in collaboration with a Steering 
Committee of 9 Australian rheumatologists.  
Purpose(s) The OPAL–QUMI is designed to both conduct large multi-
centre research projects to answer research questions, and 
directly improve clinical practice in rheumatology. 
The OPAL–QUMI will enhance the quality use of medicines 
and / or development of medical knowledge. 
Initial OPAL–QUMI research has focussed on RA but the 
group plans to develop modules and undertake research for 
other diseases in the future. 
Collection methodology Participating OPAL–QUMI clinics will use the audit software 
to capture data as part of their routine clinical practice. Pre-
specified data points (de-identified by patient, clinic and 
clinician) can be extracted, according to an approved ethics 
protocol, and aggregated to answer Australian rheumatology 
research questions.  
Scope (theoretical coverage 
of relevant population) 
All patients seeing a rheumatologist in Australia. 
 
Coverage (actual) All patients from 58 of approximately 300 Australian 
rheumatologists (~20%). 
Geographic coverage Australia. 
Frequency/timing 2009-ongoing.  
Basic collection count  Patient encounters in the rheumatology clinic, rheumatological 
diseases seen, observations relevant to disease (e.g. disease 
activity in RA), pharmacological treatments, comorbidities. 
Size >10,000 RA patients.  
Collection management 
organisation 
S4S, who produce the Audit4 software used by OPAL–QUMI 
rheumatologists, are responsible for collecting de-identified 
data, following consent from the participating clinicians. S4S 
aggregate the de-identified data and provide this to an 
independent statistician contracted by Roche. OPAL-QUMI 
Project management is undertaken by Jennifer Young, Medical 
Manager, Roche. 
Further information Contact Associate Professor Geoffrey Littlejohn at 
<geoff.littlejohn@monash.edu.au >. 
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22. Optimising Patient outcome in Australian rheumatoLogy (OPAL) (Cont.) 
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Risk factors Predictors of disease – demographics, lifestyle factors – 
smoking, alcohol, immunological factors – e.g. rheumatoid 
factor, anti-CCP antibody, etc. 
Prevalence 
and incidence 
Incidence and prevalence of rheumatological disease with 
focus particularly on rheumatoid arthritis; longitudinal study 
of measures of disease severity in rheumatoid arthritis; also 
capture all incident events including comorbidities and 
operations. 
Prevention, 
treatment and 
management 
The OPAL – QUMI focuses on patterns of treatment 
(pharmacological therapies) in specialist clinical practice to 
determine which patterns lead to the most favourable 
outcomes. 
Quality of life Disease-specific scales - e.g. modified Health Assessment 
Questionnaire – Disability Index (HAQ-DI) to measure 
functional capacity; Visual Analogue Scales for joint 
symptoms and pain as assessed by patient and clinician. 
Death and 
disability 
Priority information area is disability as measured by HAQ-
DI. 
Expenditure, 
costs 
No data. 
Population 
demographics 
Age, gender, ethnicity; postcode to determine socioeconomic 
status. 
 
  
  Data sources for monitoring arthritis and other musculoskeletal conditions  83 
23. Pharmaceutical Benefits Scheme (PBS) and Repatriation Pharmaceutical Benefits 
Scheme (RPBS) data 
Type of data source Administrative (national). 
Brief description The PBS and RPBS are national government-funded 
schemes designed to subsidise the cost of pharmaceutical 
medicines. About 80% of all prescription medications 
available for marketing in Australia are listed on the PBS or 
RPBS.  
All Australian residents and overseas visitors covered by a 
reciprocal health-care agreement requiring immediate 
medical attention are eligible for subsided medicines under 
the PBS. Eligible veterans, war widows/widowers and their 
dependants can get PBS medicines and some other 
medicines at a lower cost under the RPBS. 
The PBS and RPBS data sets contain information on the 
prescribing and dispensing of medicines outlined within 
the Schedule of Pharmaceutical Benefits. From 1 April 2012, 
data are collected for all listed pharmaceuticals purchased, 
not just the listed pharmaceuticals that receive a subsidy. 
The subsidy received depends on a person’s concession 
status. 
The PBS and RPBS data do not generally include the reason 
a medicine has been prescribed and dispensed unless the 
medicine requires an Authority approval (that is, prior 
approval from the Department of Human Services or the 
Department of Veterans' Affairs). ‘Restricted Benefit’ PBS 
items also are limited to a stated condition, but do not 
require authority approval. 
Medicines that are prescribed for musculoskeletal 
conditions that do not require an Authority approval will 
not be identifiable for monitoring purposes. 
Note: Medicines labelled ‘Authority required’ can be 
prescribed only for the conditions stated in the PBS for that 
medicine.  
Purpose(s) The PBS and RPBS were established to provide subsidised 
medicines for Australians. PBS and RPBS data provide 
information on the type of medicine, the cost of medicine 
and the volume of scripts purchased.  
Collection methodology The PBS and RPBS data sources collect information of each 
event when a person has been supplied with a PBS or RPBS 
listed pharmaceutical benefit.  
Scope (theoretical coverage of 
relevant population) 
All Australian residents, certain Australians posted 
overseas and eligible overseas visitors. 
Coverage (actual) Information will be missing if pharmacies do not lodge 
claim information. 
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23. Pharmaceutical Benefits Scheme (PBS) and Repatriation Pharmaceutical Benefits 
Scheme (RPBS) data (Cont.) 
Geographic coverage All states and territories, Australia and some overseas 
postings. 
Frequency/timing Ongoing. 
Basic collection count Number of PBS/RPBS scripts. 
Size Not applicable 
Collection management 
organisation 
The PBS is managed by the Department of Health and the 
RPBS is managed by the Department of Veterans’ Affairs. 
The PBS and the RPBS are administered by the Department 
of Human Services. 
Further information <http://www.pbs.gov.au/info/browse/statistics>. 
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Risk factors No data. 
Prevalence and 
incidence 
No data. 
Prevention, 
treatment and 
management 
Pharmaceutical use (where the pharmaceutical is listed on 
the PBS or RPBS and specific for a musculoskeletal 
condition), approximate location of pharmacy (postcode).  
Quality of life No data. 
Death and 
disability 
No data. 
Expenditure, costs Expenditure by the government and individuals on 
PBS/RPBS listed pharmaceuticals. 
Population 
demographics 
Age, sex, self-identified Indigenous status, approximate 
address (postcode).  
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24. The Survey of Disability, Ageing and Carers (SDAC) 
Type of data source Survey (national). 
Brief description The SDAC is the most detailed and comprehensive source of 
Australian population disability data.  
The survey collects national information on people with 
disabilities, older people (aged 65 or over) and their carers. In 
2012, the definition of an older person changed to 65 years and 
over (from 60 and over in the previous survey). 
The SDAC collects data on prevalence of disability, long-term 
health conditions, main disabling conditions (the conditions 
causing the most problems), type of impairments and activity 
limitations, participation restrictions in schooling and 
employment, level of participation in social and community 
activities, need for and receipt of assistance, and the need for 
and use of aids and equipment due to disability. 
The related information on long-term health conditions 
includes: osteoporosis, combined back and neck pain and 
arthritis and related disorders.  
In the SDAC, disability is defined as any limitation, restriction 
or impairment that restricts everyday activities and has lasted 
or is likely to last for at least 6 months. 
Purpose(s) To measure the prevalence of disability in the Australian 
population and the need for support of older people and 
people with disability. 
To describe a demographic and social-economic profile of the 
population with disability, older people and people providing 
care for them. 
Collection methodology Multi-stage sampling techniques are used to select the sample 
for the survey.  
The SDAC is conducted in two separate parts--the household 
component and the cared-accommodation component--using 
different data collection methods. 
Data for the household component are collected by trained 
interviewers who conduct computer-assisted personal 
interviews.  
A series of screening questions are asked of a responsible adult 
in the selected household about whether the household 
includes people with a disability, people aged 65 or older, and 
potential primary carers (and primary carers were also 
identified through information provided by recipients of care 
during their interview).  
Where possible, personal interviews are then conducted with 
people identified in any of the above populations. Personal 
interviews are also conducted with people identified as 
primary carers of people with a disability.  
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24. The Survey of Disability, Ageing and Carers (SDAC) (Cont.) 
Collection methodology 
(Cont.) 
Proxy interviews are conducted for people with a disability 
that prevented them from having a personal interview, 
children aged under 15, and those aged 15–17 whose parents 
do not permit them to be personally interviewed. 
Data for the cared-accommodation component are collected 
using a mail-based methodology directed to administrators of 
the selected establishments. This collection identifies disability 
status and assistance needs. The questions asked are similar to 
those included in the household component of the survey but 
the range of data collected in the cared accommodation is 
smaller than in the household component, as some topics are 
not suitable for completion by the administrator (e.g. 
responses based on self-perception) or are not relevant to 
people living in cared accommodation. 
Scope (theoretical coverage 
of relevant population) 
The survey covers people in private and non-private 
dwellings, including people in cared accommodation 
establishments. The scope excludes: people living in Very 
remote areas, discrete Indigenous communities, people whose 
usual residence is outside Australia, non-Australian 
diplomatic personnel and members of non-Australian defence 
forces (and their dependents) stationed in Australia.  
Population groups that are not enumerated for operational 
reasons include people in: boarding schools, and gaols or 
correctional institutions.  
Coverage (actual) The sample for the 2012 SDAC consisted of approximately 
27,400 private dwellings and 500 other non-private dwellings, 
and 1,100 establishments (cared accommodation).  
Geographic coverage All states and territories, Australia. Excludes Very remote areas.  
Frequency/timing The survey has been conducted 7 times: in 1981, 1988, 1993, 
1998, 2003, 2009 and 2012.  
Basic collection count Households, family, income unit, person, long-term health 
condition, specific activities, restrictions, providers of 
assistance, recipients of assistance.  
Size The final sample size of the 2012 SDAC comprised 68,802 
persons for the household component and 10,362 persons for 
the cared accommodation component. 
Collection management 
organisation 
ABS. 
Further information <http://www.abs.gov.au/ausstats/abs@.nsf/mf/4430.0 >. 
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24. The Survey of Disability, Ageing and Carers (SDAC) (Cont.) 
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Risk factors Information on comorbidity (other long-term health 
conditions). 
Prevalence 
and incidence 
Prevalence of arthritis and other musculoskeletal conditions 
among people with disability. 
Prevention, 
treatment and 
management 
Aids used, assistance received, unmet needs for aids or 
assistance. The 2012 SDAC collected information about the use 
of health services among people with disability. 
Quality of life Self-perception of health and wellbeing, ability to participate 
in social and community activities. Limitations imposed on 
mobility and self-care, requirement for assistance, 
employment limitations. 
Information is also provided on the impact of the caring role 
on carers, including carers’ self-perception of health and 
wellbeing. 
Death and 
disability  
The SDAC data are one of the sources for the Australian 
Burden of Disease study. 
Expenditure, 
costs 
No data on direct costs or expenditure related to disability or 
caring for people with disability are collected in the SDAC. 
Information is provided about employment restrictions of 
people with disability and carers along with the main effect of 
the caring role on carers’ financial situation. 
Population 
demographics 
Age, sex, Indigenous status, country of birth, year of arrival in 
Australia, main language spoken at home, proficiency in 
spoken English, broad location of respondent (capital city or 
rest of state), household and family structure, income, 
educational attendance and attainment, housing tenure type, 
living arrangements, marital status. 
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25. The Tasmanian Older Adult Cohort (TASOAC) 
Type of data source Longitudinal (regional). 
Brief description The TASOAC study is a longitudinal study set in southern 
Tasmania examining the determinants of osteoarthritis and 
osteoporosis in community dwelling older adults. 
Purpose(s) To identify the environmental, genetic, and biochemical 
factors associated with the development and progression of 
osteoporosis and osteoarthritis at multiple sites (hand, knee, 
hip, and spine).  
Collection methodology Self-completed interview, physical measurements, use of a 
pedometer, blood samples, magnetic resonance imaging (MRI) 
scans, bone densitometry (DXA), radiography. 
Scope (theoretical coverage 
of relevant population) 
Men and women aged 50 to 80 randomly sampled from the 
electoral roll in southern Tasmania, stratified by sex. 
Institutionalised persons were excluded. 
Coverage (actual) 1,099 attended a baseline clinic between March 2002 and 
September 2004 (a response rate of 57%). At the phase 2 
follow-up, 1,000 were eligible for follow-up and data was 
collected for 875 participants. Phase 3 follow-up data was 
collected for 769 participants.  
Geographic coverage Southern Tasmania 
Frequency/timing 2002 onwards. Enrolment and a baseline clinic occurred 
between March 2002 and September 2004. Phase 2 follow-up 
occurred about 2.7 years later. Phase 3 follow-up occurred 
about 5 years later. A 10-year follow-up of this cohort is under 
way (June 2013 onwards).  
Basic collection count  Persons. 
Size 769 participants in the phase 3 follow-up.  
Collection management 
organisation 
Menzies Research Institute Tasmania, University of Tasmania 
Further information <http://www.menzies.utas.edu.au/information.php?Doo=Vi
ewData&type=Project&ID=21>.  
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25. The Tasmanian Older Adult Cohort (TASOAC) (Cont.) 
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Risk factors Body mass index, smoking, alcohol consumption, dietary 
calcium, physical activity, medications--glucocorticoids and 
hormone therapy (females only)--Vitamin D from blood 
samples, sunlight exposure, falls risk determined using the 
short form Physiological Profile Assessment. 
Prevalence 
and incidence 
Doctor-diagnosed osteoarthritis and rheumatoid arthritis. 
Osteoporosis and osteopenia prevalence from bone mineral 
density measured using dual-energy X-ray absorptiometry 
(knee, hip). 
Knee and hip radiographic osteoarthritis assessed using 
radiography and the Altman atlas, and MRI to assess cartilage 
defects. 
Osteoarthritis severity (pain, stiffness and functional ability) 
was assessed using the Western Ontario and McMaster 
Universities Osteoarthritis Index. Self-reported level of pain by 
joint/area (neck, shoulders, back, hips, hands, knees and feet). 
Prevention, 
treatment and 
management 
Medication use, joint replacement surgery. 
Quality of life Self-assessed quality of life, level of pain by joint/area (not 
necessarily related to arthritis or musculoskeletal conditions). 
Death and 
disability  
Deaths. 
Expenditure, 
costs 
No data. 
Population 
demographics 
Age, sex, residential address, SEIFA. 
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26. Voice of Arthritis Social Impact Study 
Type of data source Survey (national). 
Brief description This research study, carried out in March 2004, explored how 
arthritis (osteoarthritis and rheumatoid arthritis) affects the 
individual, their family or carer and their workplace. 
Information is gathered relating to respondents’ satisfaction 
with health services, the support they receive from family or 
carers, and their ability to participate in work and other 
activities. 
Purpose(s) To establish and confirm Arthritis Australia’s understanding 
of all aspects of arthritis and how it affects sufferers, their 
families/carers and their workplaces, enabling Arthritis 
Australia to prioritise effort and investment in raising 
awareness of arthritis throughout Australia. 
Collection methodology The survey was a paper based self-completion questionnaire 
mailed in March 2004 to 3000 people with arthritis by each 
State Arthritis office from their database. 
Scope (theoretical coverage 
of relevant population) 
3000 people on State Arthritis foundation databases. 
Coverage (actual) A response of 1,016 was received before the survey’s closing 
date, representing a response rate of 34%. 
Geographic coverage Australia. 
Frequency/timing March 2004. 
Basic collection count Persons. 
Size 1,016 responses. 
Collection management 
organisation 
The study was conducted by The Leadership Factor, an 
international research agency, on behalf of Arthritis Australia.  
Further information <http://www.arthritisaustralia.com.au/images/stories/docu
ments/reports/2011_updates/the%20voice%20of%20arthritis
%202004.pdf>. 
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26. Voice of Arthritis Social Impact Study (Cont.) 
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Risk factors No data. 
Prevalence 
and incidence 
No data. 
Prevention, 
treatment and 
management 
Satisfaction and perceived level of benefit with treatment and 
management such as medication and surgery. 
Quality of life Impact of arthritis on quality of life, physical health, mental 
health, burden on family or carers and ability to participate in 
social events and paid work. 
Death and 
disability 
No data. 
Expenditure, 
costs 
Respondents rated the level of impact of their arthritis on their 
financial position, and rated the impact of factors such as 
medication costs and the effect of lost wages. 
Population 
demographics 
Age, sex. 
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27. The 45 and Up Study 
Type of data source Longitudinal survey (state). 
Brief description The 45 and Up Study is a longitudinal study of people from 
NSW. It follows the health of participants to examine which 
factors are associated with good or poor health as people 
age. Survey responses are linked to other health databases, 
allowing a broad view of health service use and outcomes.  
The study collects information about osteoarthritis and 
osteoporosis. Participants are able to nominate other 
important illnesses, so other musculoskeletal conditions 
will be noted.  
Purpose(s) To develop a research resource to boost understanding of 
how Australians are ageing. This will answer important 
health and quality-of-life questions and help manage and 
prevent illness through improved knowledge of health. 
Collection methodology Potential participants were randomly sampled from the 
Medicare Australia database and mailed a study 
questionnaire and information leaflet. Individuals from 
rural areas and those aged 80 and over were oversampled.  
Participants joined the study by completing the 
questionnaire and providing signed consent for follow-up 
and linkage to a range of health databases. Information 
available through data linkage includes: health service use 
from the Medicare Benefits Scheme (Medicare) and 
Pharmaceutical Benefits Scheme (PBS) databases, 
hospitalisation data from the National Hospital Mortality 
Database (NHMD) (with details of patterns of care), aged 
care and mortality data. 
Scope (theoretical coverage of 
relevant population) 
The NSW population, with a higher likelihood of selection 
for those in rural areas and those aged 80 and over.  
Coverage (actual) The study has recruited more than 250,000 men and 
women from the NSW general population. The response 
rate to the study is approximately 18%. 
Geographic coverage NSW. 
Frequency/timing 2006-2009 for the first survey, and 2012-15 for the second, 
with more surveys to be run in the future. Data linkage 
began in 2008. 
Basic collection count Persons. 
Size More than 250,000 people. 
Collection management 
organisation 
The Sax Institute 
Further information <https://www.saxinstitute.org.au/our-work/45-up-
study/>. 
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27. The 45 and Up Study (Cont.) 
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Risk factors Physical activity, smoking, alcohol consumption, 
comorbidities, BMI, hours spent outdoors (relevant for 
vitamin D). 
Prevalence and 
incidence 
The first-round survey asks whether participants have been 
treated for osteoarthritis or osteoporosis and their age at 
first treatment, whether they have any other important 
illness and how they are treated. 
The second survey also asks whether respondents have 
been diagnosed with osteoarthritis by a doctor, and age at 
diagnosis. 
Fracture data available from the survey and the hospitals 
database. 
The survey collects data on general health limitations. 
Prevention, 
treatment and 
management 
Primary health service use from the Medicare database 
(reason for treatment may not be available). 
Medication use, both self-reported and from the PBS 
database (reason for prescription of the medication may not 
be available). 
Longitudinal hospitalisation data from the NHMD. 
Outcomes such as surgical revisions, mortality. 
Quality of life Self-rated quality of life, functional capacity, level of 
psychological distress. 
Death and 
disability 
No data. 
Expenditure, costs Costs data from the linked data sources: Medicare, PBS, 
NHMD. 
Population 
demographics 
Age, postcode, education level, ethnicity, country of birth, 
year of arrival in Australia, language spoken at home, 
Indigenous status, housing type, relationship status, 
household income. 
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This report assesses the potential for existing data 
sources to improve our understanding of arthritis 
and other musculoskeletal conditions and highlights 
future opportunities for improving data for monitoring 
these conditions. A 4-step process is used to assess 
the utility of different data sources to provide relevant 
information on the 6 priority information areas required 
for monitoring these conditions. This methodological 
approach may also be useful for monitoring a range of 
other health conditions.
